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ABSTRACT OF DISSERTATION
AGGREGATED QUANTITATIVE MULTIFACTOR DIMENSIONALITY
REDUCTION
We consider the problem of making predictions for quantitative phenotypes based on
gene-to-gene interactions among selected Single Nucleotide Polymorphisms (SNPs).
Previously, Quantitative Multifactor Dimensionality Reduction (QMDR) has been
applied to detect gene-to-gene interactions associated with elevated quantitative phe-
notypes, by creating a dichotomous predictor from one interaction which has been
deemed optimal. We propose an Aggregated Quantitative Multifactor Dimensional-
ity Reduction (AQMDR), which exhaustively considers all k-way interactions among
a set of SNPs and replaces the dichotomous predictor from QMDR with a continu-
ous aggregated score. We evaluate this new AQMDR method in a series of simula-
tions for two-way and three-way interactions, comparing the new method with the
original QMDR. In simulation, AQMDR yields consistently smaller prediction error
than QMDR when more than one significant interaction is present in the simulation
model. Theoretical support is provided for the method, and the method is applied
on Alzheimer’s Disease (AD) data to identify significant interactions between APOE4
and other AD associated SNPs.
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Chapter 1
Introduction
1.1 Multifactor Dimensionality Reduction
The detection and characterization of susceptibility genes for common complex
diseases such as atrial fibrillation, autism, breast cancer, and hypertension (among
many others) has long been a concern in the field of genetics. These diseases often have
inheritance patterns that are complex [2]. Due to advancements in the availability
and cost-efficiency of genotypic data, Single Nucleotide Polymorphisms (SNPs) have
been used to explore variation in susceptibility to such diseases [1]. Abundance of
such data has raised concerns regarding traditional, parametric statistical methods.
For example, logistic regression is frequently used for models involving categorical
predictor variables and categorical response variables [2]. However, using genotypes
as predictors in these models and a phenotype (or clinical outcome) as the response is
not ideal, as logistic regression is ill-equipped to handle high-dimensional data which
may result in contingency table cells which are empty [3]. It is possible to remedy
this problem with large sample sizes, but of course, this may come at high expense to
researchers. To avoid this, alternative non-parametric solutions have been developed
in recent years, which can be applied to smaller sample sizes from case-control and
discordant-sib-pair studies [2].
One such alternative solution, Multifactor Dimensionality Reduction (MDR) was
developed by Ritchie et al. [2], and inspired by the combinatorial partitioning method
[4]. MDR is a method for characterizing and identifying nonlinear complex gene-to-
gene interactions which may be related to susceptibility to complex diseases. MDR
converts high dimensional genotypic data into a single predictive variable by identi-
fying gene-to-gene interactions as “high risk” or “low risk” [1]. MDR is appealing be-
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cause it can identify non-linear epistasis (significant gene-to-gene interactions) with no
assumptions about underlying distributions of predictors (genotypes) or phenotypic
outcomes (apart from the dichotomous nature of these outcomes), and no requirement
for large sample sizes [5].
The MDR method can be implemented in four general steps. Note that a balanced
case-control study is typical for Ritchie’s original MDR approach. In step 1, a set of
genotypic (SNPs) and/or categorical environmental factors are selected from all pos-
sible factors. In step 2, an interaction among these factors is selected and represented
by cells or multifactor classes which represent genotypic combinations within that
interaction. For example, a two-way interaction for SNPs with three states can be
represented by a 3× 3 table, where each cell in the table is a genotypic combination
or multifactor class. For a case-control study, the ratio of the number of cases to the
number of controls is calculated within each multifactor class. In a discordant-sib-
pair study, the ratio of the number of affected sibs to the number of unaffected sibs
is calculated within each multifactor class. In step 3, each of the multifactor cells is
identified as“high risk”or“low risk”. We define a“high risk”cell as any multifactor cell
in which the cases:controls ratio is greater than or equal to some pre-defined thresh-
old. Cells in which cases:controls is less than the threshold are defined as “low risk”.
In balanced case-control studies, a commonly used threshold is 1 [2]. Extensions to
the original MDR method have focused on changing this threshold to accommodate
unbalanced case control studies, in order to avoid assigning a “high risk” classification
simply due to dominance of cases over controls in the data [6]. Then the “high risk”
cells are pooled into a group, and the “low risk” cells are pooled into another group.
The result is a one-dimensional model, that is, a single binary variable which takes a
value of 1 if a subject is “high risk” and 0 otherwise.
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In step 4, 10-fold cross-validation is used to estimate the prediction error of each
one-dimensional model. In this process, the data are divided into ten equal subsets
and MDR is performed on nine of the subsets (the training data), and used to make
predictions about the remaining subset of subjects (validation data). Prediction error
is estimated by calculating the proportion of subjects for which an incorrect prediction
is made. The process is repeated ten times using one of the subsets for validation
data, and the prediction error is averaged over the ten repetitions [2].
The four steps of the MDR method are repeated for each possible two-factor combi-
nation. Among all possible two-factor combinations, the model which maximizes the
cases:controls ratio for the “high risk” group is selected as a candidate model. Then,
this process is repeated in consideration of three-way gene-to-gene interactions, and
a candidate three-way model is chosen. Eventually, a candidate model is selected for
each of two to n way gene-to-gene interactions (resulting in n-1 candidate models).
Among the set of candidate models, the one which minimizes the prediction error av-
eraged over the ten repetitions of cross validation is selected as the best overall model.
Finally, the optimal model is evaluated for statistical significance using 1000 count
permutation testing. In this process, the distribution of the cross validation consis-
tencies (under the null hypothesis that the gene-to-gene interaction is not associated
with disease status) is estimated empirically by shuffling the response variable (per-
muting), and performing 10-fold cross validation. For each permutation, consistency
of the selected model across cross validation sets (the number of times the selected
model is identified as optimal in each possible 9/10 of the subjects) is calculated. The
average cross validation consistency from the original data set is compared to the dis-
tribution of average consistencies found empirically from 1000 permutations, under
the null hypothesis of no association. A model is said to be statistically significant
if the relative frequency of average consistencies obtained by permutation which are
3
greater than the cross validation consistency obtained from the original data is less
than .05 [2]. The MDR method is illustrated in figure 1.1, which has been adapted
from a similar figure produced by Ritchie et al. [2].
Figure 1.1: The steps of MDR [2].
Software for implementing the MDR algorithm has been developed by Hahn et
al. [5], Bush et. al. [7], Winham and Motsinger-Reif [8] and Moore [9] and the
method has been widely used in the analysis of SNP data relating to common complex
diseases. Despite the advantages of MDR in detecting and characterizing gene-to-gene
interactions which are associated with disease susceptibility, the method does have
some limitations. MDR can be computationally intensive when more than ten SNPs
are included in a data set [2]. For example, consider a data set which includes M
SNPs. There are
(
M
k
)
possible k-way combinations. For large values of M , the number
of combinations which are to be considered can become overwhelming. In some cases,
MDR can be combined with a filter preprocess to select the optimal number of SNPs
to include in MDR [1]. The original MDR approach is also strictly applicable to
phenotypes with binary outcomes (absence or presence of a disease, for example).
Many extensions to the MDR method have been investigated in order to make the
4
method applicable to quantitative outcomes, and to replace “high risk” and “low risk”
susceptibility categories with a quantifier. Some of these extensions are discussed in
this work.
1.2 Quantitative Traits
An area of interest concerning MDR involves the extension of the method to ac-
count for quantitative outcomes (phenotypes). Rather than focusing on discrete,
dichotomous outcomes, researchers may be interested in continuous outcomes such
as body mass index, survival time, and tumor growth. In these cases, the original
MDR method [2] cannot be applied. Several methods have been suggested in order
to address this possible extension. One such method is Generalized MDR (GMDR),
which is based on the score statistic of generalized linear models [10]. This extension
of MDR allows continuous phenotypes by replacing the ratio of cases and controls
which was used in MDR with a score-based statistic for a given cell. This statistic
is used to classify gene-to-gene interactions (cells) as “high risk” or “low risk” [10].
Another approach to identifying interactions for quantitative traits is Model-based
MDR (MB-MDR), which implements parametric regression within the MDR method
[11].
Unfortunately, when considering quantitative phenotypes, GMDR and MB-MDR
are not computationally efficient. Further, although an R package has been devel-
oped to implement Model-based MDR, this package does not consider gene-to-gene
interactions with higher dimension than three [12]. To address the possible limi-
tations of these two methods, Gui [12] suggests an extension of the original MDR
method called Quantitative MDR (QMDR). The steps involved in implementation
of QMDR are analogous to the original method. However, instead of comparing the
cases:controls ratio within each multifactor cell to some threshold, we compare the
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mean value within each multifactor cell to the overall mean. If the mean value for a
genotypic combination is greater than the overall mean, the combination is considered
to be in the “high-level” group, and if it is lower than the overall mean, the combi-
nation is “low-level”. Once again, a new one-dimensional, binary variable is created
by pooling subjects within “high-level” multifactor classes into a group and subjects
within “low-level” multifactor classes into another.
Recall that in MDR, prediction error was used to evaluate the possible models.
A 0-1 prediction error is meaningless for quantitative outcomes, so Gui suggests the
use of a T-statistic calculated based on the difference in the “high-level” group mean
and the “low-level” group mean as a training score to be maximized when selecting
the best k-way interaction model. Cross-validation is performed in the same way,
except we calculate a testing score based on assigning subjects in the testing data
into “high-level” and “low-level” groups in regard to the classification obtained from
the training data. We maximize the testing score to select the optimal model out
of all candidate models. The final model is then evaluated for statistical significance
with permutation testing. Gui tested the model against the GMDR method, and
found that QMDR provided similar results to GMDR with decreased computation
time [12].
1.3 Aggregated Multifactor Dimensionality Reduction
Another extension to Ritchie’s original method was developed by Dai et al.[1], whose
notation we adopt in the sequel. Aggregated-Multifactor Dimensionality Reduction
(A-MDR) replaces the dichotomous “high risk” and “low risk” groups designated in
the original MDR method with an epistasis enriched risk score. This risk factor aims
to quantify disease susceptibility. The A-MDR method is described here. Assume
we have SNPs which occur in one of three states: 0-homozygous, 1-heterozygous,
6
2-homozygous variant. For example, consider a SNP which contains one allele, with
three possible states: AA, Aa, and aa. Then 0 is assigned to AA, 1 to Aa, and 2 to
aa. In the first step of A-MDR, the predisposing risk factor is calculated as follows:
Suppose we are interested in k-way gene-to-gene interactions among M different SNP
factors. For one such k-way interaction, there are 3k possible combinations, because
SNP(1) has three possible states (0, 1, 2), SNP(2) has three possible states, and so
forth. There are also
(
M
k
)
k-way gene-to-gene interactions among M SNP factors.
Let j = 1, 2, ..., 3k represent all possible genotypic combinations (or multifactor
cells) within a k-way gene-to-gene interaction. Let i = 1, 2, ...,
(
M
k
)
represent all
possible k-way interactions among M SNPs. Let Xi,j be the number of cases in the
jth genotypic combination of the ith k-way gene-to-gene interaction. Similarly, let Yi,j
be the number of control subjects in the jth genotypic combination of the ith k-way
gene-to-gene interaction. These counts are used to create a threshold. A genotypic
combination is classified as “highly susceptible” if the disease risk associated with that
combination is greater than the threshold defined as:
p0 =
3k∑
j=1
Xi,j
3k∑
j=1
Xi,j +
3k∑
j=1
Yi,j
(1.1)
Note that this threshold itself is an extension of the original MDR method, because
it does not assume a balanced case-control study. Gene-to-gene interactions are then
classified into “high risk” and “low risk” groups as shown in the contingency table
(table 1.1), which is reproduced from Dai et al. [1]. Note that I[∗] represents an
indicator function which takes a value of 1 if [∗] is true and 0 otherwise. This table
accounts for N subjects in a study. Dai suggests three different measures calculated
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Table 1.1: Predisposing Risk Table, reproduced from Dai et al. [1]
Case Control Total
High Risk n11 =
3k∑
j=1
XijI[
Xij
Xij+Yij
> p0] n12 =
3k∑
j=1
YijI[
Xij
Xij+Yij
> p0] n1+
Low Risk n21 =
3k∑
j=1
XijI[
Xij
Xij+Yij
≤ p0] n22 =
3k∑
j=1
YijI[
Xij
Xij+Yij
≤ p0] n2+
Total n+1 n+2 N
from the contingency table (table 1.1), which can be used to evaluate the statistical
significance of a k-way gene-to-gene interaction. These include the predisposing odds
ratio (pOR), the predisposing chi-square (pChi) and the predisposing relative risk
(pRR). To date, using inference based on normal or χ2 asymptotic distributions with
one degree of freedom (as is typically appropriate for contingency table analysis) has
not been justified in this case. As a result, permutation testing has been be used to
assess significance [1]. Formulas for the three measures are as follows:
pORi =
n11n22/(n12n21)
F−10 (F (n11n22/(n12n21)))
(1.2)
pRRi =
n11/(n11+n12)
n21/(n21+n22)
F−10 F (
n11/(n11+n12)
n21/(n21+n22)
)
(1.3)
pChii =
2∑
s=1
2∑
t=1
(nst−est)2
est
F−10 F (
2∑
s=1
2∑
t=1
(nst−est)2
est
)
. (1.4)
Note that pChi is the based on the traditional calculation of a χ2 test statistic, where
nst is the “observed” value in a contingency table cell, and est is the “expected” value
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for the cell under the null hypothesis of no association. The expected value for each
cell is calculated by est =
ns+n+t
N
[1].
Regardless of the chosen measure (pOR, pRR or pChi), it is necessary to calcu-
late F (x) and F−10 (x), where x is the numerator of the chosen measure provided
in (1.2), (1.3) and (1.4). For example, if the measure of interest is pOR, then
x = n11n22/(n12n21). Note that the denominators in each of these measure calcu-
lations are necessary only to facilitate the interpretation of 95% confidence intervals.
That is, exempting the occurrence of a type II error, confidence intervals for each
statistic (pOR, pRR or pChi) will contain 1 when H0 (no interaction is present) is
true. We can calculate the cumulative distribution of x under the alternative hypoth-
esis that a gene-to-gene interaction is present in nature, and call it F (x). Similarly,
let F0(x) denote the cumulative distribution function under the null hypothesis that
the interaction is not present, and F−10 be the inverse of F0(x). We estimate these
cumulative distributions empirically. In order to estimate F0(x), the phenotypes are
permuted among individuals in the data set while the SNPs (factors) are maintained
for each individual. For each of these permutations, the chosen statistic (the numer-
ator from (1.2), (1.3) or (1.4)) is computed. This process is repeated, say 1000 times,
allowing a cumulative distribution function of the statistic under the null hypothesis
to be estimated empirically. The logic here is that if no relationship between the
predisposing risk and disease status is present, then pOR, pRR, or pChi obtained
from the original data will be similar to those obtained by permuting the response
variable. F (x) is estimated empirically through a process known as jackknife resam-
pling. Subsets of the data are selected such that 80 − 90% of the data are used to
calculate the numerator from (1.2), (1.3) or (1.4), and again, a cumulative distribution
function for a statistic is estimated from many, say 1000 repetitions of this process.
We use F (x) and F−10 (x) in the calculation of pOR, pRR and pChi. F0(x) is used to
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calculate a p-value for the statistic (the numerator from (1.2), (1.3) or (1.4)) obtained
from the original data (call it z), by calculating the percentage of statistics from the
permutations that are greater than z [1].
For subject n (noting that n may be a new subject for which a prediction is to
be made or n ∈ {1, 2, ..., N}), an aggregated k-way epistasis enriched risk score is
calculated as follows:
R(k, n) =
(Mk )∑
i=1
I[pvali < α̂] 3k∑
j=1
I[n ∈ Cij]I
[
Xij
Xij + Yij
> p0
] (1.5)
where α̂ = argmax[AUC|α] for 0 ≤ α ≤ .05, Cij represents the cell corresponding to
genotypic combination j within gene-to-gene interaction i, and pvali is the p-value
obtained from the permutation process performed on the chosen measure. Notice that
the aggregated risk score only includes the significant k-way gene-to-gene interactions
and those which are assigned to the “high risk” group. The area under a receiver
operating characteristic curve (AUC) is maximized over possible values of α ∈ [0, .05]
to maximize the risk score’s ability to predict disease susceptibility [1].
1.4 Motivation and Outline of this Work
Current methodology allows for the aggregation of cumulative effects of multiple
gene-to-gene interactions regarding dichotomous phenotypes. Progress has been made
in the identification of significant gene-to-gene interactions under the consideration of
quantitative phenotypes. In this work, we will examine a new approach to predicting
quantitative phenotypes in which the effects from multiple significant interactions are
combined to form a continuous, aggregated score to be used in a model for prediction.
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In chapter 2, we will propose a new method, Aggregated Quantitative Multifactor
Dimensionality Reduction (AQMDR), in which the dichotomous categorization from
Quantitative Multifactor Dimensionality Reduction (QMDR) is replaced by a contin-
uous score developed by accumulating effects from multiple (or all possible) k-way
gene-to-gene interactions. We propose three distinct aggregated scores, which dictate
which interactions are included in the model, and the weight assigned to each of these
interactions. We apply these aggregated scores to simulated data, and evaluate the
method in the realm of two-way interactions.
In chapter 3, we will extend the AQMDR method to three-way interactions, and
look at accumulating effects from two-way and three-way interactions.
In chapter 4, we will explore quadratic models as opposed to simple linear models
in the context of AQMDR.
In chapter 5, we will provide theoretical support for the AQMDR method.
In chapter 6, we will apply the methodology of this work to a real-world data set.
We will seek to explore interactions between the epsilon 4 allele of the APOE gene and
several other genetic factors that are known to be associated with AD. In particular,
we want to examine how these interactions influence the quantitative factors CSF Aβ
and CSF tau.
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Chapter 2
AQMDR and Considerations for Two-way Interactions
2.1 Aggregated Score for Quantitative Phenotypes
In the present work, an Aggregated Quantitative Multifactor Dimensionality Re-
duction (AQMDR) method is proposed, in which gene-to-gene interactions are consid-
ered exhaustively to generate aggregated scores. This score improves on Quantitative
Multifactor Dimensionality Reduction [12] and replaces the dichotomous predisposing
risk factor from the original QMDR. We introduce the new methodology, and propose
three distinct aggregated scores. We evaluate the method through simulation study
with focus on two-way gene-to-gene interactions.
In the following sequence, we adopt the notation of Dai et al. [1] where appro-
priate. For concreteness, we present the proposed AQMDR method with respect to
SNPs with three common states (0-homozygous reference, 1- heterozygous, 2 - ho-
mozygous variant). The method can be extended to incorporate interactions among
other explanatory variables (e.g. environmental factors) which are categorical in na-
ture. Suppose we are interested in k-way gene-to-gene interactions among M SNPs.
There are 3k possible genotypic combinations (recalling that each SNP exhibits three
possible states). We denote these combinations as Cij, where the j = 1, 2, ..., 3
k in-
dex different genotypic combinations within one k-way gene-to-gene interaction and
i = 1, 2, ...,
(
M
k
)
represents the possible k-way interactions among M SNPs. For ex-
ample, for a 2-way gene-to-gene interaction, we can think of the Cij as cells in a 3× 3
table. Figure 2.1 shows a two-way interaction between SNP 1 and SNP 2, each of
which contain one allele with three possible states (AA, Aa, aa, BB, Bb, bb). Each
of the nine cells represents a Cij (the j
th genotypic combination within the ith k-way
gene-to-gene interaction).
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Figure 2.1: A two-way interaction between SNP 1 and SNP 2
Departing from the notation of Dai et al. [1], suppose we consider N subjects and
a continuous phenotype Y . Let Ȳij be the mean value of Y among subjects exhibiting
genotypic combination j of the ith k-way gene-to-gene interaction. Let Ȳ denote the
overall mean of Y among the N subjects. Genotypic combinations are classified into
groups based on Ȳij. Combinations in which Ȳij > Ȳ are classified as “high” and
receive a value of 1 and all others are classified as “low” and receive a value of 0. In
figure 2.2, the mean of Y among subjects in each cell is given (Ȳij), as well as the
grand mean, Ȳ . Shaded cells represent those receiving a classification of “high” (1)
and white cells represent those receiving a classification of “low” (0).
Figure 2.2: Cell classification of a two-way interaction.
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After all genotypic combinations in the ith k-way gene-to-gene interaction are iden-
tified as “high” or “low” combinations, the subjects within the “high” group are pooled
together, and the “low” group subjects are pooled as well. Then these groups are used
to calculate the following test statistic for the ith k-way interaction:
t∗ =
Ȳhigh − Ȳlow√
sd2high
nhigh
+
sd2low
nlow
(2.1)
where sdhigh is the standard deviation among phenotypes of the nhigh individuals
classified as “high”, sdlow is the standard deviation among phenotypes of the nlow
individuals classified as “low”. Note that this test statistic was inspired by the QMDR
method [12].
As the parametric distribution of this test statistic is unknown, permutation test-
ing is used to evaluate the significance of the ith k-way interaction. For permutation
testing, we shuffle the Y outcomes while keeping genotypes fixed. For each permuta-
tion of the phenotype, “high” and “low” classifications are reassigned, and the t∗ test
statistic is recalculated. After many repetitions, say 1000, we calculate the relative
frequency of the t∗’s calculated from permutation which are greater than or equal to
the t∗ calculated from the original data. This relative frequency is then used as a
p-value.
This process is repeated for all
(
M
k
)
k-way gene-to-gene interactions resulting in
a one-dimensional binary variable identifying whether subjects are in the “high” or
“low” group and a p-value for each interaction. These binary variables and p-values
are then used to calculate an aggregated score for each subject. In this work, we
define and compare three possible aggregated scores.
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2.2 Aggregated Score with a Convex Weighting Function
The first aggregated score is characterized by a convex weighting function, designed
to assign weights to gene-to-gene interactions based on the p-values obtained through
permutation testing. With this weighting function, interactions with low p-values
are assigned high weights, and those with high p-values receive lower weights. For
interpretability and proper comparison among individuals, the risk score is presented
on a scale between 0 and 1, where values close to 1 are assigned to individuals most
at risk for elevated values of the phenotype. This aggregated score, referred to as the
Convex Weighting Aggregated Score (CWAS) in this work, for individual n, where
k-way interactions are considered is calculated as follows:
CWAS(k, n) =
(Mk )∑
i=1
(1− pval1/2i )
3k∑
j=1
I[n ∈ Cij]I[Ȳij > Ȳ ]
(Mk )∑
i=1
(1− pval1/2i )
(2.2)
where pvali is the p-value for gene-to-gene interaction i obtained from permutation
testing. Note that this aggregated score (as well as the other two aggregated scores
to be defined in this work) may be calculated for an individual in the original data
set, or for a new individual.
2.3 Aggregated Score with an Arbitrary Cutoff
The second proposed aggregated score is inspired by the score proposed for binary
phenotypes by Dai et al. [1]. This score is based on an arbitrary cutoff for the
Monte Carlo p-values for the gene-to-gene interactions obtained from permutation
testing. Interactions with p-values less than this cutoff value are included in the
aggregated score, and all others are omitted. Choosing the arbitrary cutoff is left to
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the researcher, but cutoffs of .05 and .20 will be considered later in this work. This
aggregated score will be referred to as the Arbitrary Cutoff Aggregated Score (ACAS)
in this work. Let c be the cutoff chosen for inclusion in the aggregated score. The
Arbitrary cutoff score is calculated as follows:
ACAS(k, n) =
(Mk )∑
i=1
I[pvali < c]
3k∑
j=1
I[n ∈ Cij]I[Ȳij > Ȳ ]
(Mk )∑
i=1
I[pvali < c]
(2.3)
Should an investigator encounter a situation in which none of the Monte Carlo p-
values for the
(
M
k
)
interactions are less than c (resulting in an undefined aggregated
score), a larger value of c may be considered.
2.4 Hybrid Aggregated Score
The third and final proposed aggregated score is a hybrid of the first two aggregated
scores. A weight of 1 is assigned to interactions which produced p-values less than a
cutoff (again, call this cutoff value c), and the same convex weight function discussed
in section 2.2 is applied to those interactions with p-values greater than the cutoff.
In this work, we will refer to this aggregated score as the Hybrid Aggregated Score
(HAS). HAS can be calculated as follows:
HAS(k, n) =
A+B(
M
k
) (2.4)
where
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A =
(Mk )∑
i=1
I[pvali < c]
3k∑
j=1
I[n ∈ Cij]I[Ȳij > Ȳ ] (2.5)
and
B =
(Mk )∑
i=1
I[pvali ≥ c](1− pval1/2i )
3k∑
j=1
I[n ∈ Cij]I[Ȳij > Ȳ ] (2.6)
2.5 The Aggregated Score as a Predictor
Recall that the original QMDR method results in a single, binary variable to be
used as a predictor of phenotype values. This binary variable corresponds to the
“high” or “low” categorization produced by the gene-to-gene interaction deemed to
be optimal [12]. By calculating an aggregated score with AQMDR, we replace the
dichotomous predictor with a continuous predictive variable. The aggregated score
allows us to incorporate all k-way gene-to-gene interactions, or some subset of the
interactions (significant interactions) to more adequately predict values of a quantita-
tive phenotype. The potential advantage of QMDR over our method is that QMDR
explicitly identifies which particular gene-to-gene interaction may be driving changes
in phenotypes among individuals. However, if accurate prediction of a phenotype
is the goal, AQMDR may provide a better predictor for linear regression with the
phenotype. AQMDR may be most useful in situations where more than one gene-to-
gene interaction influences the phenotype. The aggregated score may be extended to
incorporate environmental factors, and the aggregated scores from multiple orders of
interaction may be combined (for example, the accumulation of two-way and three-
way gene-to-gene interactions). The latter idea will be explored in a later chapter of
this work.
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2.6 Empirical Assessment for Two-way Gene-to-gene Interactions
An extensive simulation study was performed to assess the performance of the
AQMDR method in detection and making predictions based upon two-way interac-
tions. The study is a factorial design in which we examined variations of the number
of SNPs to be considered and the number of interactions present in nature. Let M
be the number of SNPs under consideration, and x be the number of two-way in-
teractions present. SNPs were generated under the assumption of Hardy-Weinberg
equilibrium [13]. For example, consider a SNP, call it SNPA, with two alleles, each
of which take states of A or a. We let the probability that an individual carries allele
A on a single chromosome be p = .5, and the probability that a person carries allele
a on a single chromosome be q = .5. Then the SNP states AA and aa each have
probability p2 = .25 and q2 = .25 of occurring. SNP state Aa occurs with probability
2pq = .5. Phenotypes for individuals were randomly generated by a N(120, σ2) distri-
bution, where the mean of this normal distribution was increased by the presence of
an interaction. For example, suppose that the two-way interaction of SNP1 and SNP2
was included in simulation. Then the mean of the random normal distribution used
to generate the phenotype was increased by 30 in the event that an individual carried
a genotypic combination such as (SNP1 = 2)(SNP2 = 2). This example simulation
model is displayed in equation 2.7.
In the factorial simulation study, we varied the standard deviation, σ of the normal
distribution used to generate phenotypes as well. See table 2.1 for the particular
variations considered in this factorial simulation study. Each training and testing
data set contained phenotypes and SNP states for 1000 simulated subjects. If one
interaction was present, SNP1× SNP2 was selected as the present interaction. If three
interactions were present in simulation, SNP1 × SNP2, SNP1 × SNP3, and SNP1 ×
SNP4 were the interactions selected. If six interactions were present in simulation,
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SNP1 × SNP2, SNP1 × SNP3, SNP1 × SNP4, SNP2 × SNP3, SNP2 × SNP4,
and SNP3 × SNP4 were included. For each interaction, the homozygous variant
(SNP=2) was used to define an interaction leading to an elevated phenotype, and all
interactions were generated using the same magnitude of elevation. That is, the mean
of the random normal was increased by 30 in the presence of each interaction.
Yi = 120 + 30(I[SNP1i = 2]I[SNP2i = 2]) + εi, εi
iid∼ N(0, σ2) (2.7)
Table 2.1: The values of variants considered in the two-way interaction factorial
simulation study.
M x σ
4 1 10
10 3 15
6 20
The AQMDR method aims to produce more accurate predictions for quantitative
phenotypes than current methodology. Thus, the focus of this simulation study is on
quality of prediction. For each combination of variants (as shown in table 2.1) 100
independent training and testing data sets were generated. We applied the AQMDR
method to each set of training data and subsequently made predictions for the test-
ing data. Each of the proposed aggregated scores (CWAS, ACAS and HAS) were
implemented in the AQMDR method and compared. ACAS and HAS were varied by
using c = .05 and c = .20. For further comparison, we considered three alternative
methods of prediction. The first method was the original QMDR method developed
by Gui et al. [12] and discussed extensively in section 1.2 of this work. The second
method involved using the overall mean for the phenotype in the training data as the
prediction for all of the phenotype values in the testing data. For simplicity, we refer
to this prediction method as the training mean (TM) method. The final alternative
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prediction method was based on knowledge of the truth used for simulation. For
example, if it was known that an interaction between SNP1 and SNP2 was present
in the simulation, the presence of (SNP1=2)(SNP2=2) resulted in an increased mean
for the normal distribution used to generate the phenotype. Thus, in this method
(referred to as the oracle method), a binary variable in which individuals carrying
a genotypic combination ((SNP1=2)(SNP2=2) in the previous example) receive a
value of 1 is used as a linear predictor of the phenotype. Multiple present interactions
result in multiple linear predictors. As this method is based on knowledge of the
truth, we included it in this simulation study as a best-case-scenario (in the absence
of dimensionality reduction) for comparison. After predictions for the phenotypes
in the testing data were made based on the training data, mean squared prediction
error (MSPE) was calculated for each testing set. Equation 2.8 shows the MSPE for
n observations (yi’s) and the corresponding predictions (ŷi’s).
MSPE =
n∑
i=1
(yi − ŷi)2
n
(2.8)
The results of the factorial simulation study are displayed in table 2.2. Each value in
the table is the average MSPE over 100 independent repetitions of generating training
and testing data sets. The first three columns of the table indicate the variants of
M , x and σ used in the simulation scenario for each row. Columns four through nine
correspond to implementations of AQMDR using the indicated proposed aggregated
scores. A value under the header such as .05 and .20 indicates the chosen cutoff value
c in ACAS and HAS. The final three columns correspond to the alternative prediction
methods, QMDR, the oracle method, and the training mean method, respectively.
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As shown in table 2.2, when more than one gene-to-gene interaction is present,
the average MSPEs are consistently lower for the AQMDR implementations when
compared to the traditional QMDR method. In these cases, the AQMDR method
demonstrated more adequate predictions. This is apparent, regardless of which of the
aggregated scores were implemented in the AQMDR method. However, the lowest
MSPEs for cases where x > 1 occurred when applying the Arbitrary Cutoff aggregated
score with c = .05. These results provide evidence that AQMDR may be providing
more predictive ability in scenarios where multiple gene-to-gene interactions affect
the phenotype (x > 1).
Table 2.2: Average MSPE over 100 independent testing data sets for two-way inter-
action simulation study.
M x σ CWAS ACAS
(.05)
ACAS
(.20)
HAS
(.05)
HAS
(.20)
QMDR Oracle TM
4 1 10 127.19 126.59 127.27 128.30 128.09 107.78 100.55 153.96
4 1 15 255.00 254.51 254.79 255.92 255.80 247.02 225.65 277.17
4 1 20 437.61 437.03 437.40 439.31 438.87 431.89 403.66 456.85
10 1 10 133.91 131.25 132.91 131.82 133.47 109.41 100.61 153.67
10 1 15 262.52 258.09 260.87 259.29 261.85 247.03 225.28 277.70
10 1 20 444.32 438.73 440.95 440.42 442.51 435.32 402.44 454.40
4 3 10 203.78 203.78 203.78 203.78 203.78 225.70 99.57 320.45
4 3 15 331.22 331.26 331.26 331.26 331.26 354.72 225.45 448.18
4 3 20 505.97 506.35 506.20 506.36 506.20 525.42 402.17 620.46
10 3 10 223.39 220.25 223.18 220.87 223.68 226.41 100.41 320.52
10 3 15 349.97 345.91 350.19 346.67 350.87 352.16 224.93 446.17
10 3 20 528.69 523.60 528.67 524.69 529.72 527.73 400.41 623.86
4 6 10 423.23 423.23 423.23 423.23 423.23 561.48 101.14 675.00
4 6 15 554.04 554.04 554.04 554.04 554.04 693.65 227.01 805.64
4 6 20 719.00 719.00 719.00 719.00 719.00 856.36 403.00 970.46
10 6 10 338.23 329.28 336.23 330.49 337.40 561.73 101.42 674.75
10 6 15 458.38 450.28 456.92 451.36 457.97 683.20 225.75 800.40
10 6 20 631.19 622.48 630.08 623.71 631.07 844.66 402.48 954.56
To further explore the distinctions between methods in the simulation study, a
single factor, within-subjects ANOVA was performed for each simulation scenario,
followed by post hoc multiple pairwise comparisons among the aggregated scores and
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alternative methods. For all simulation scenarios, the ANOVA yielded significance
at α = .05 level, suggesting that there are differences among the average MSPEs for
the prediction methods. The prediction methods were ranked according to the results
from multiple pairwise comparisons. The rankings from multiple pairwise comparisons
with a Bonferroni correction based on the total number of comparisons (α = .05
28
) are
displayed in table 2.3. For each simulation scenario (a row in the table), prediction
methods were assigned rankings a, b , c, etc. where a is the ranking assigned to the
method with the lowest average MSPE. Methods sharing a letter ranking were not
determined to be statistically significant in a pairwise comparison.
Table 2.3: Within-subjects ANOVA with a Bonferroni correction, α = .05
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for two-way
interaction simulation study.
M x σ CWAS ACAS
(.05)
ACAS
(.20)
HAS
(.05)
HAS
(.20)
QMDR Oracle TM
4 1 10 c c c c c b a d
4 1 15 c c c c c b a d
4 1 20 b b b b b b a d
10 1 10 d c c c d b a e
10 1 15 d c c c d b a e
10 1 20 d c c cd d b a e
4 3 10 b b b b b c a d
4 3 15 b b b b b c a d
4 3 20 b b b b b c a d
10 3 10 c b b b c d a e
10 3 15 c b b b c d a e
10 3 20 c b b b c c a d
4 6 10 b b b b b c a d
4 6 15 b b b b b c a d
4 6 20 b b b b b c a d
10 6 10 b b b b b c a d
10 6 15 b b b b b c a d
10 6 20 b b b b b c a d
First, notice that the AQMDR method performs significantly better than QMDR
in all scenarios with x > 1. As expected, QMDR excels in those cases with a single
interaction present. In scenarios with only four SNPs, the five proposed aggregated
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scores within AQMDR are not significantly different. When M = 10, we see that the
five aggregated scores begin to differ, and in all of these cases the ACAS with c = .05
always yields lower average MSPEs.
Table 2.4 displays the average testing R2 values for each prediction method within
each simulation scenario. When comparing the average R2 values of QMDR with
the AQMDR aggregated scores, we clearly see that AQMDR outperforms QMDR
in all scenarios with x > 1. For example, the advantage of AQMDR is especially
apparent when M = 10, x = 6 and σ = 20. In this case, QMDR produced an R2
of approximately 11.51%, while AQMDR (with ACAS, c = .05) produced an R2 of
approximately 34.79%.
Table 2.4: Average testing R2 values (as percentages) for two-way interaction simu-
lation study.
M x σ CWAS ACAS
(.05)
ACAS
(.20)
HAS
(.05)
HAS
(.20)
QMDR Oracle
4 1 10 17.39% 17.78% 17.34% 16.67% 16.80% 29.99% 34.69%
4 1 15 8.00% 8.18% 8.07% 7.67% 7.71% 10.88% 18.59%
4 1 20 4.21% 4.34% 4.26% 3.84% 3.94% 5.46% 11.64%
10 1 10 12.86% 14.59% 13.51% 14.22% 13.15% 28.80% 34.53%
10 1 15 5.47% 7.06% 6.06% 6.63% 5.71% 11.04% 18.88%
10 1 20 2.22% 3.45% 2.96% 3.08% 2.62% 4.20% 11.43%
4 3 10 36.41% 36.41% 36.41% 36.41% 36.41% 29.57% 68.93%
4 3 15 26.10% 26.09% 26.09% 26.09% 26.09% 20.85% 49.70%
4 3 20 18.45% 18.39% 18.42% 18.39% 18.42% 15.32% 35.18%
10 3 10 30.30% 31.28% 30.37% 31.09% 30.21% 29.36% 68.67%
10 3 15 21.56% 22.47% 21.51% 22.30% 21.36% 21.07% 49.59%
10 3 20 15.26% 16.07% 15.26% 15.90% 15.09% 15.41% 35.82%
4 6 10 37.30% 37.30% 37.30% 37.30% 37.30% 16.82% 85.02%
4 6 15 31.23% 31.23% 31.23% 31.23% 31.23% 13.90% 71.82%
4 6 20 25.91% 25.91% 25.91% 25.91% 25.91% 11.76% 58.47%
10 6 10 49.87% 51.20% 50.17% 51.02% 50.00% 16.75% 84.97%
10 6 15 42.73% 43.74% 42.91% 43.61% 42.78% 14.64% 71.80%
10 6 20 33.88% 34.79% 33.99% 34.66% 33.89% 11.51% 57.84%
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In table 2.5, we see the ratios of each prediction method average testing R2 value
to that of the oracle method. For the AQMDR aggregated scores, these ratios tend
to be larger for scenarios with multiple interactions present. The opposite is true of
QMDR, where increases in x produce smaller ratios.
An interesting finding in the simulation study can be seen in those simulation sce-
narios with six interactions present in nature (x = 6). Focusing on the AQMDR
implementations, one can see that average MSPEs for scenarios with four SNPs and
six significant interactions present were consistently larger than the average MSPEs
for scenarios with ten SNPs and six significant interactions (see table 2.2). In other
words, the more complicated simulation scenario (ten SNPs) produced better pre-
dictions than the less complicated scenario (four SNPs). This phenomenon may be
related to overestimation of an individual’s phenotype value when he/she carries mul-
tiple (or all) of the gene-to-gene interactions present in nature.
Table 2.5: Method:Oracle R2 Ratio for two-way interaction simulation study.
M x σ CWAS ACAS
(.05)
ACAS
(.20)
HAS
(.05)
HAS
(.20)
QMDR
4 1 10 0.50 0.51 0.50 0.48 0.48 0.86
4 1 15 0.43 0.44 0.43 0.41 0.41 0.59
4 1 20 0.36 0.37 0.37 0.33 0.34 0.47
10 1 10 0.37 0.42 0.39 0.41 0.38 0.83
10 1 15 0.29 0.37 0.32 0.35 0.30 0.59
10 1 20 0.19 0.30 0.26 0.27 0.23 0.37
4 3 10 0.53 0.53 0.53 0.53 0.53 0.43
4 3 15 0.53 0.52 0.52 0.52 0.52 0.42
4 3 20 0.52 0.52 0.52 0.52 0.52 0.44
10 3 10 0.44 0.46 0.44 0.45 0.44 0.43
10 3 15 0.43 0.45 0.43 0.45 0.43 0.42
10 3 20 0.43 0.45 0.43 0.44 0.42 0.43
4 6 10 0.44 0.44 0.44 0.44 0.44 0.20
4 6 15 0.43 0.43 0.43 0.43 0.43 0.19
4 6 20 0.44 0.44 0.44 0.44 0.44 0.20
10 6 10 0.59 0.60 0.59 0.60 0.59 0.20
10 6 15 0.60 0.61 0.60 0.61 0.60 0.20
10 6 20 0.59 0.60 0.59 0.60 0.59 0.20
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Chapter 3
Higher Order Interactions
3.1 Empirical Assessment for Three-way Gene-to-gene Interactions
In 2001, Ritchie et. al [2] identified a four-way gene-to-gene interaction related
to sporadic breast cancer. Based on this and other similar findings, we may be in-
terested in the consideration of higher order interactions. Currently, we turn our
attention toward three-way interactions in the context of the same AQMDR method
and proposed aggregated scores discussed in chapter 2. Again, we performed a simu-
lation study using a factorial design in which we examined variations of the number
of SNPs to be considered (M) and the number of present interactions (x). SNPs were
generated in the same manner discussed in chapter 2. Phenotypes for subjects were
generated using a N(120, σ2) distribution. The mean of this normal distribution was
increased by 30 with the presence of a three-way interaction. For example, suppose
that an interaction between SNP1, SNP2 and SNP3 was included in a simulation sce-
nario. In this case, the mean of the random normal distribution used to generate the
phenotype was increased in the event that an individual carried a genotypic combi-
nation such as (SNP1 = 2)(SNP2 = 2)(SNP3 =2). This example simulation scenario
is displayed in equation 3.1. In the factorial simulation study, we varied the standard
deviation of the normal distributions used to generate the phenotypes. See table 3.1
for the particular variations considered in this study. Each training and testing data
set contained phenotypes and SNP states for 1000 subjects.
Yi = 120 + 30(I[SNP1i = 2]I[SNP2i = 2]I[SNP3i = 2]) + εi, εi
iid∼ N(0, σ2) (3.1)
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Table 3.1: The values of variants considered in the three-way interaction factorial
simulation study.
M x σ
4 1 10
10 2 15
20
For each combination of variants (M , x, σ), 100 independent training and testing
data sets were generated. We applied the AQMDR method to each set of training data
and subsequently made predictions for the testing data. The methods considered were
the same as those described in chapter 2, including AQMDR (ACAS and HAS with
cutoffs of c = .05 and c = .20, and CWAS), QMDR, the training mean method and
the oracle method. As we considered only three-way interactions in this simulation
study, the QMDR method was limited only to the selection of three-way interaction
models. After predictions for the phenotypes in the testing data were made based
on the training data, the mean squared prediction error (MSPE) was calculated for
each testing set using equation 2.8. The results of the factorial simulation study
are displayed in table 3.2. Each value in the table is the average MSPE over 100
independent testing data sets. If one interaction was present in simulation, SNP1
× SNP2 × SNP3 was used. If two interactions were present in simulation, SNP1
× SNP2 × SNP3 and SNP1 × SNP2 × SNP4 were used. For each interaction, the
homozygous variant (SNP=2) was used to define an interaction leading to an elevated
phenotype, and all interactions were generated using the same magnitude of elevation.
That is, the mean of the random normal was increased by 30 in the presence of each
interaction.
As we saw with two-way interactions, QMDR performs well when only one interac-
tion is present (x = 1). In scenarios with more than one present interaction, AQMDR
yields lower MSPEs than QMDR. This is apparent, regardless of which of the aggre-
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gated scores were implemented in AQMDR. These results provide empirical evidence
that AQMDR may provide more predictive ability than QMDR in scenarios where
multiple three-way gene-to-gene interactions act on the phenotype.
Table 3.2: Average MSPE over 100 independent testing data sets for three-way in-
teraction simulation study.
M x σ CWAS ACAS
(.05)
ACAS
(.20)
HAS
(.05)
HAS
(.20)
QMDR Oracle TM
4 1 10 117.26 117.26 117.26 117.26 117.26 105.21 100.17 208.32
4 1 15 250.27 250.32 250.32 250.32 250.32 249.87 225.50 332.00
4 1 20 435.61 436.10 436.09 436.29 436.27 441.55 400.84 508.61
10 1 10 147.45 144.75 146.96 144.89 147.07 106.28 99.91 208.83
10 1 15 271.20 265.96 271.13 266.25 271.34 246.01 223.67 330.63
10 1 20 456.11 447.47 455.27 447.94 455.64 438.04 400.56 507.22
4 2 10 152.08 152.08 152.08 152.08 152.08 201.06 101.15 345.97
4 2 15 278.18 278.18 278.18 278.18 278.18 323.70 223.56 470.72
4 2 20 457.59 457.59 457.59 457.59 457.59 497.20 397.00 644.16
10 2 10 175.67 173.43 174.89 173.50 174.96 200.34 100.27 346.25
10 2 15 303.76 301.19 302.78 301.28 302.87 323.12 225.83 468.38
10 2 20 487.30 483.83 485.95 483.97 486.08 508.05 401.86 646.56
As we observed with the two-way interactions, it appears that the arbitrary cut-
off aggregated score (ACAS) with c = .05 tends to yield average MSPEs which are
a bit more favorable than the other four implementations of AQMDR. To see this
distinction a bit more clearly, a single factor, within-subjects ANOVA was performed
for each of the twelve simulation scenarios, followed by post hoc multiple pairwise
comparisons among the aggregated scores and alternative methods. In each simula-
tion scenario, the ANOVA yielded significance at α = .05 level, suggesting that there
are differences among the average MSPEs for the methods. Prediction methods were
ranked according to results from multiple pairwise comparisons (with a Bonferroni
correction, α = .05
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). These rankings are displayed in table 3.3. For each simula-
tion scenario (represented by a row in the table), prediction methods were assigned
rankings a, b, c, etc. where a is the ranking assigned to the method with the lowest
average MSPE. Recall from chapter 2 that methods sharing a letter ranking were not
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determined to be statistically significant in a pairwise comparison (that is, there is
no significant difference between the methods).
Table 3.3: Within-subjects ANOVA with a Bonferroni correction, α = .05
28
for three-
way interaction simulation study.
M x σ CWAS ACAS
(.05)
ACAS
(.20)
HAS
(.05)
HAS
(.20)
QMDR Oracle TM
4 1 10 c c c c c b a d
4 1 15 c c c c c b a d
4 1 20 b b b b b c a d
10 1 10 d c cd c d b a e
10 1 15 d c d c d b a e
10 1 20 d c d c d b a e
4 2 10 b b b b b c a d
4 2 15 b b b b b c a d
4 2 20 b b b b b c a d
10 2 10 b b b b b c a d
10 2 15 b b b b b c a d
10 2 20 b b b b b c a d
As we saw in scenarios for two-way interactions, AQMDR performs significantly
better than QMDR in scenarios in which more than one three-way interaction is
present, and thus receives a higher letter ranking in all such scenarios. Recall from
chapter 2 that QMDR always performed better than AQMDR in situations with x =
1, but for three-way interactions this is not always the case. With a smaller number of
SNPs (M = 4), a single present interaction and σ = 20, we see that AQMDR performs
better than expected and has a higher ranking than QMDR. However, when M = 10,
we see that QMDR provides average MSPEs that are consistently lower than those
of AQMDR. When x = 2, the AQMDR methods are ranked higher than QMDR in
all cases, providing evidence that AQMDR may provide more adequate predictions
than QMDR when multiple three-way interactions are present (regardless of which
aggregated score is used). In nearly all scenarios, the five variations of AQMDR are
not significantly different. In fact, differences among the AQMDR aggregated scores
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are only present when we have ten SNPs and one present three-way interaction. In
these cases, the arbitrary cutoff aggregated score and the hybrid aggregated score
(with c = .05) perform a bit better than the other three variations of AQMDR, with
the convex weighting aggregated score yielding the highest MSPEs.
Table 3.4 displays the average R2 values (as percentages) for each prediction method
within each simulation scenario. As we saw in the simulation study for two-way
interactions, these R2 values decrease as σ increases, and tend to be higher when
there are four SNPs under consideration rather than ten. Table 3.5 displays the
Table 3.4: Average R2 values (as percentages) for three-way interaction simulation
study.
M x σ CWAS ACAS
(.05)
ACAS
(.20)
HAS
(.05)
HAS
(.20)
QMDR Oracle
4 1 10 43.71% 43.71% 43.71% 43.71% 43.71% 49.50% 51.92%
4 1 15 24.62% 24.60% 24.60% 24.60% 24.60% 24.74% 32.08%
4 1 20 14.35% 14.26% 14.26% 14.22% 14.22% 13.18% 21.19%
10 1 10 29.39% 30.69% 29.63% 30.62% 29.57% 49.11% 52.16%
10 1 15 17.97% 19.56% 18.00% 19.47% 17.93% 25.59% 32.35%
10 1 20 10.08% 11.78% 10.24% 11.69% 10.17% 13.64% 21.03%
4 2 10 56.04% 56.04% 56.04% 56.04% 56.04% 41.89% 70.76%
4 2 15 40.90% 40.90% 40.90% 40.90% 40.90% 31.23% 52.51%
4 2 20 28.96% 28.96% 28.96% 28.96% 28.96% 22.81% 38.37%
10 2 10 49.26% 49.91% 49.49% 49.89% 49.47% 42.14% 71.04%
10 2 15 35.15% 35.70% 35.36% 35.68% 35.34% 31.01% 51.78%
10 2 20 24.63% 25.17% 24.84% 25.15% 24.82% 21.42% 37.85%
ratios of each prediction method average R2 value to that of the oracle method. As
we saw with two-way interactions, these ratios for the AQMDR aggregated scores tend
to be larger when more than one three-way interaction is present, and the opposite is
true for QMDR.
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Table 3.5: Method:Oracle R2 Ratio for three-way interaction simulation study.
M x σ CWAS ACAS
(.05)
ACAS
(.20)
HAS
(.05)
HAS
(.20)
QMDR
4 1 10 0.84 0.84 0.84 0.84 0.84 0.95
4 1 15 0.77 0.77 0.77 0.77 0.77 0.77
4 1 20 0.68 0.67 0.67 0.67 0.67 0.62
10 1 10 0.56 0.59 0.57 0.59 0.57 0.94
10 1 15 0.56 0.60 0.56 0.60 0.55 0.79
10 1 20 0.48 0.56 0.49 0.56 0.48 0.65
4 2 10 0.79 0.79 0.79 0.79 0.79 0.59
4 2 15 0.78 0.78 0.78 0.78 0.78 0.59
4 2 20 0.75 0.75 0.75 0.75 0.75 0.59
10 2 10 0.69 0.70 0.70 0.70 0.70 0.59
10 2 15 0.68 0.69 0.68 0.69 0.68 0.60
10 2 20 0.65 0.67 0.66 0.66 0.66 0.57
3.2 Combining Two-way and Three-way Interactions
Now we turn our attention toward the simultaneous consideration of two-way and
three-way interactions. If two-way and three-way interactions are considered using
the QMDR technique, candidate interactions are selected for k = 2 and k = 3. Then
10-fold cross-validation is used to choose a single, optimal interaction among these
candidates to be used in the regression model. Rather than choosing between k = 2
and k = 3, we propose three distinct extensions to AQMDR in which the aggregated
scores for two-way and three-way interactions are considered simultaneously. The
three proposed approaches are as follows:
1. Sequential Inclusion - In this extension, the aggregated scores for two-way
and three-way interactions are considered sequentially. That is, the aggregated
score for k = 2 (two-way interactions) is developed and used as a predictor in
a regression model for the phenotype. Then, the residuals from this regression
are regressed on the aggregated score for k = 3 (three-way interactions).
2. Simultaneous Inclusion - In this extension, the aggregated scores for two-
way and three-way interactions are considered simultaneously. That is, the
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aggregated scores for k = 2 and k = 3 are both used as predictors in a single
regression model for the phenotype.
3. Principal Components - In this extension, the first principal component of
the aggregated score for k = 2 and the aggregated score for k = 3 is used as a
predictor in a regression model for the phenotype.
To compare these three approaches with the QMDR method, we perform an exten-
sive simulation study. In each simulation, we consider ten SNPs (M = 10) and SNP
states are generated using Hardy-Weinberg Equilibrium [13]. For example, consider
a SNP, call it SNPA, with two alleles, each of which take states of A or a. We let the
probability that an individual carries allele A on a single chromosome be p = .5, and
the probability that a person carries allele a on a single chromosome be q = .5. Then
the SNP states AA and aa each have probability p2 and q2 of occurring. SNP state
Aa occurs with probability 2pq. In previous simulation studies, p was fixed at p = .5.
For this study, the value of p for each SNP is generated using a continuous uniform
distribution on (.5, .9). Phenotypes for individuals were randomly generated by a
N(120, 152) distribution, where the mean of this normal distribution was increased
by 30 with the presence of an interaction. For example, suppose that the two-way
interaction of SNP1 and SNP2 was included in simulation, and the three-way inter-
action of SNP3, SNP4 and SNP5 was included as well. Then the mean of the random
normal distribution used to generate the phenotype was increased in the event that
an individual carried a genotypic combination such as (SNP1 = 2)(SNP2 = 2), or the
genotypic combination (SNP3 = 2)(SNP4 = 2)(SNP5 = 2). This example simulation
scenario is defined as
Yi = 120 + 30(I[SNP1i = 2]I[SNP2i = 2])
+ 30(I[SNP3i = 2]I[SNP4i = 2]I[SNP5i = 2]) + εi
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where εi
iid∼ N(0, 152).
In table 3.6, the “1-way” column indicates which of the ten SNPs considered in sim-
ulation (SNPA, SNPB,..., SNPJ) are included as a one-way interaction (main effect).
For example, if SNPJ is included as a main effect in simulation, then ”J” appears
in this column. The “2-way” column indicates which two-way interactions were in-
cluded. For example, if the interaction between SNPA and SNPB was included in
simulation, then AB appears in this column. Similarly, the “3-way” column indicates
which three-way interactions were included. For example, if the interaction between
SNPC, SNPD and SNPE was included in simulation, then “CDE” appears in this
column. The magnitude of all one-way, two-way and three-way interactions included
in simulation was 30. That is, the presence of an interaction in simulation increased
the mean of the random normal distribution by 30. When calculating aggregated
scores in the AQMDR method, the arbitrary cutoff aggregated score with a cutoff of
c = .05 was used. This aggregated score was selected because previous simulations
indicated that this particular score may have a slight advantage over the other pro-
posed scores. In table 3.6, the “Seq.” column corresponds to the Sequential Inclusion
method, the “Sim.” column corresponds to the Simultaneous Inclusion approach, and
the “P.C.” column corresponds to the Principal Components method. Each value in
these columns is the average MSPE calculated from 100 independent testing data
sets. For discussion that follows, we have assigned a numerical value to each scenario
in the first column of table 3.6.
There were some simulation scenarios in which we expected QMDR to perform well,
specifically scenarios with a single present interaction (either a three-way interaction
or a two-way interaction) such as scenarios 2, 4, and 6. QMDR is well-suited for
these situations because the method selects a single “optimal” interaction among all
possible two-way and three-way interactions. Looking at the MSPEs for these three
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scenarios, we see that QMDR did indeed produce smaller average MSPEs than the
three AQMDR implementations. Table 3.7 displays the results of post hoc multiple
pairwise comparisons among the prediction methods, performed after single factor,
within subjects ANOVA tests which all yielded significance at the α = .05 signifi-
cance level. The prediction methods were ranked according to the multiple pairwise
comparisons (with Bonferroni correction, α = .05
10
), where a ranking of a is assigned to
the method with the lowest MSPE. As in previous sections, methods sharing a letter
ranking were not determined to be statistically different. If we look at scenario num-
bers 2, 4, and 6 in table 3.7, we see that the difference between QMDR and the three
AQMDR methods is statistically significant (as they don’t share a letter ranking).
QMDR also yielded significantly lower MSPEs in scenarios 3 and 5. In both of
these scenarios, we have two three-way interactions present and no present two-way
interactions. QMDR may have performed well in scenarios 3 and 5 because it selects
one of the two present three-way interactions as the optimal interaction. Even though
QMDR will ignore the other interaction which is not deemed optimal, it may pro-
duce better predictions than AQMDR. In fact, as the AQMDR methods include an
aggregated score for two-way interactions when there are actually no two-way inter-
actions present, the two-way aggregated scores may incorporate unnecessary two-way
interactions due to confounding with the present three-way interactions. However, we
did not see the same results when there were multiple two-way interactions and no
three way interactions present. This can be seen in scenario 11, where the AQMDR
methods yielded lower MSPEs than QMDR.
In more complicated simulation scenarios in which there were a combination of two-
way and three-way interactions (such as scenarios 9, 10, 12, 13, 14, 15), the AQMDR
approaches resulted in lower average MSPEs than QMDR. With the exception of
scenarios 7 and 8, the differences between the AQMDR methods and QMDR were
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statistically significant (see table 3.7). In scenarios 16-30, the first fifteen simulation
scenarios were repeated with the addition of a single main effect. With the exception
of scenario 16 (in which no two-way or three-way interactions were present), AQMDR
provided more adequate predictions than QMDR for all of these scenarios, with sta-
tistically significant differences between the AQMDR approaches and QMDR. Note
that in scenarios 7 and 8, the Simultaneous Inclusion implementation of AQMDR
yielded a lower average MSPE than QMDR, but the Sequential Inclusion and Princi-
pal Components implementations both yielded higher average MSPEs than QMDR.
Pairwise comparisons in scenarios 7 and 8 determined that Simultaneous Inclusion,
Principal Components and QMDR were not significantly different, but Sequential In-
clusion performed significantly worse than QMDR and the other two implementations
of AQMDR.
In several scenarios (scenarios 3, 6, 11 and 18), there were no significant differences
among the three AQMDR approaches for inclusion of two-way and three-way interac-
tions. All four of these scenarios are scenarios in which there were either no two-way
interactions present, or no three-way interactions present. In all other scenarios (with
the exception of scenarios 1 and 16 in which no two-way or three-way interactions
were present), Simultaneous Inclusion and Principal Components are slightly favor-
able over Sequential Inclusion. Simultaneous Inclusion and Principal Components
were not significantly different in any of the simulation scenarios with the exception
of scenario 1.
Table 3.8 displays the average R2 values (as percentages) for the simulation scenar-
ios. One can see that these average R2 values tend to be higher when a main effect
is included in the simulation (scenarios 16-30).
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Table 3.6: Average MSPEs for two-way and three-way interactions combined.
No. 1-way 2-way 3-way Seq. P.C. Sim. QMDR TM
1 - - - 240.02 236.45 239.69 229.69 225.49
2 - - ABE 273.58 261.44 261.20 229.65 427.74
3 - - ABE & CDF 272.03 260.41 261.85 229.85 429.08
4 - - EFG 270.43 260.03 261.68 230.93 429.75
5 - - EFG & HIJ 268.50 257.28 258.02 229.04 420.92
6 - AB - 276.57 268.59 267.84 230.91 381.19
7 - AB ABE 332.05 310.38 301.97 311.47 622.86
8 - AB ABE & CDF 327.36 307.80 301.70 304.53 614.35
9 - AB EFG 313.17 294.00 292.28 358.02 581.11
10 - AB EFG & HIJ 309.87 290.69 288.42 358.65 583.58
11 - AB & CD - 314.14 300.61 303.04 355.12 540.66
12 - AB & CD ABE 366.72 339.59 339.34 465.36 768.77
13 - AB & CD ABE & CDF 367.72 339.94 338.14 481.86 791.92
14 - AB & CD EFG 349.83 326.19 327.28 511.12 749.87
15 - AB & CD EFG & HIJ 348.32 325.15 326.83 511.89 738.48
16 J - - 234.79 228.98 230.71 227.02 431.37
17 J - ABE 277.43 262.18 261.74 359.98 637.26
18 J - ABE & CDF 278.91 262.92 261.85 366.59 638.97
19 J - EFG 275.66 261.64 261.74 363.91 639.04
20 J - EFG & HIJ 271.56 257.94 258.51 352.67 630.41
21 J AB - 295.75 276.33 271.15 296.91 586.28
22 J AB ABE 333.72 308.15 305.91 488.95 832.80
23 J AB ABE & CDF 329.56 304.58 302.56 481.66 819.86
24 J AB EFG 318.15 295.20 295.72 482.74 786.77
25 J AB EFG & HIJ 316.42 293.29 292.92 489.47 784.29
26 J AB & CD - 328.99 305.46 305.49 451.17 747.47
27 J AB & CD ABE 367.91 340.29 341.44 635.78 981.25
28 J AB & CD ABE & CDF 366.24 339.03 340.91 651.35 994.43
29 J AB & CD EFG 353.67 328.51 330.26 646.87 964.19
30 J AB & CD EFG & HIJ 351.97 326.85 329.04 637.61 947.39
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Table 3.7: Within-subjects ANOVA with a Bonferroni correction, α = .05
10
No. 1-way 2-way 3-way Seq. P.C. Sim. QMDR TM
1 - - - d c d b a
2 - - ABE c b b a d
3 - - ABE & CDF c b b a c
4 - - EFG c b b a d
5 - - EFG & HIJ c b b a d
6 - AB - b b b a c
7 - AB ABE b a a a c
8 - AB ABE & CDF b a a a c
9 - AB EFG b a a c d
10 - AB EFG & HIJ b a a c d
11 - AB & CD - a a a b c
12 - AB & CD ABE b a a c d
13 - AB & CD ABE & CDF b a a c d
14 - AB & CD EFG b a a c d
15 - AB & CD EFG & HIJ b a a c d
16 J - - b ab ab a c
17 J - ABE b a a c d
18 J - ABE & CDF b a a c d
19 J - EFG b a a c d
20 J - EFG & HIJ b a a c d
21 J AB - b a a c d
22 J AB ABE b a a c d
23 J AB ABE & CDF b a a c d
24 J AB EFG b a a c d
25 J AB EFG & HIJ b a a c d
26 J AB & CD - b a a c d
27 J AB & CD ABE b a a c d
28 J AB & CD ABE & CDF b a a c d
29 J AB & CD EFG b a a c d
30 J AB & CD EFG & HIJ b a a c d
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Table 3.8: Average R2 values (as percentages) for two-way and three-way interactions
combined
No. 1-way 2-way 3-way Seq. P.C. Sim. QMDR
1 - - - -6.44% -4.86% -6.30% -1.86%
2 - - ABE 36.04% 38.88% 38.93% 46.31%
3 - - ABE & CDF 36.60% 39.31% 38.97% 346.43%
4 - - EFG 37.07% 39.49% 39.11% 46.26%
5 - - EFG & HIJ 36.21% 38.88% 38.70% 45.59%
6 - AB - 27.45% 29.54% 29.74% 39.42%
7 - AB ABE 46.69% 50.17% 51.52% 49.99%
8 - AB ABE & CDF 46.71% 49.90% 50.89% 50.43%
9 - AB EFG 46.11% 49.41% 49.70% 38.39%
10 - AB EFG & HIJ 46.90% 50.19% 50.58% 38.54%
11 - AB & CD - 41.90% 44.40% 43.95% 34.32%
12 - AB & CD ABE 52.30% 55.83% 55.86% 39.47%
13 - AB & CD ABE & CDF 53.57% 57.07% 57.30% 39.15%
14 - AB & CD EFG 53.35% 56.50% 56.36% 31.84%
15 - AB & CD EFG & HIJ 52.83% 55.97% 55.74% 30.68%
16 J - - 45.57% 46.92% 46.52% 47.37%
17 J - ABE 56.47% 58.86% 58.93% 43.51%
18 J - ABE & CDF 56.35% 58.85% 59.02% 42.63%
19 J - EFG 56.86% 59.06% 59.04% 43.05%
20 J - EFG & HIJ 56.92% 59.08% 58.99% 44.06%
21 J AB - 49.55% 52.87% 53.75% 49.36%
22 J AB ABE 59.93% 63.00% 63.27% 41.29%
23 J AB ABE & CDF 59.80% 62.85% 63.10% 41.25%
24 J AB EFG 59.56% 62.48% 62.41% 38.64%
25 J AB EFG & HIJ 59.66% 62.60% 62.65% 37.59%
26 J AB & CD - 55.99% 59.13% 59.13% 39.64%
27 J AB & CD ABE 62.51% 65.32% 65.20% 35.21%
28 J AB & CD ABE & CDF 63.17% 65.91% 65.72% 34.50%
29 J AB & CD EFG 63.32% 65.93% 65.75% 32.91%
30 J AB & CD EFG & HIJ 62.85% 65.50% 65.27% 32.70%
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Chapter 4
Model Selection
4.1 Introduction
In previous chapters of this work, we used a simple linear regression to model the
quantitative outcome variable against the predictor derived from AQMDR, known
as the aggregated score. The reasoning behind this model selection was in interest
of consistent comparison with current methodology. However, a general strategy for
this type of analysis may require model selection. We have shown that AQMDR is
an adequate method for developing a predictor, but in some cases a simple linear
regression including the aggregated score may be improved upon by performing poly-
nomial regression, or by taking other transformations of the aggregated score. In this
chapter, we provide a simple example of this model selection, and simulation results
for the new model.
4.2 The Quadratic Model
Consider an example scenario with 4 SNPs of interest (SNP1, SNP2, SNP3, SNP4)
and an outcome variable which is simulated with a normal distribution, where the
mean of this normal distribution was increased by the presence of interactions. That
is,
Yi = 120 + 30I[SNP1i = 2]I[SNP2i = 2] + 30I[SNP1i = 2]I[SNP3i = 2]
+ 30I[SNP1i = 2]I[SNP4i = 2] + εi
(4.1)
where εi
iid∼ N(0, 16) and Yi is the value of some quantitative trait for individual i.
For 1000 simulated testing subjects, the aggregated score using an arbitrary cutoff
of c = .05 (ACAS) based on 1000 training subjects was calculated. The scatterplot
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of Y vs. the numerator of the arbitrary cutoff aggregated score for the testing data
is displayed in figure 4.1. By examining this plot, one can see that a simple linear
Figure 4.1: Scatterplot of Y vs. the Numerator of the Aggregated Score
regression may not be appropriate in this case. In fact, the relationship between the
response and the aggregated score seems to follow a parabolic pattern. Based on this
visual analysis, a quadratic model may be a better fit. In fact, suppose we have the
following:
Full model: Yi = β0 + β1AggregatedScorei + β2AggregatedScore
2
i + εi
Reduced model: Yi = β0 + β1AggregatedScorei + εi
where εi
iid∼ N(0, σ2). If we examine the hypotheses H0 : β2 = 0 vs H1 : β2 6= 0, we
observe a p-value that is less than .001, and reject H0. Thus, we determine that the
full, quadratic model is a better fit than the reduced, simple linear model.
With the exception of the variance used in simulation of phenotypes, simulation
model 4.1 is very similar to the simulation scenarios used in previous chapters of this
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work. In what follows, we recreate the simulation scenarios presented in chapter 2
and chapter 3, but this time we also use the following quadratic data analysis model
to replace the simple linear data analysis model previously employed in AQMDR:
Yi = β0 + β1AggregatedScorei + β2AggregatedScore
2
i + εi (4.2)
where εi
iid∼ N(0, σ2).
4.3 Simulation Results: Two-way Interactions
Recall the simulation scenarios for two-way interactions presented in chapter 2 of
this work. The study was a factorial design in which we examined variations of the
number of SNPs to be considered and the number of interactions present in nature.
Let M be the number of SNPs under consideration, and x be the number of two-way
interactions present. SNPs were generated under the assumption of Hardy-Weinberg
equilibrium [13]. For example, consider a SNP, call it SNPA, with two alleles, each
of which take states of A or a. We let the probability that an individual carries
allele A on a single chromosome be p = .5, and the probability that a person carries
allele a on a single chromosome be q = .5. Then the SNP states AA and aa each
have probability p2 = .25 and q2 = .25 of occurring. SNP state Aa occurs with
probability 2pq = .5. Phenotypes for individuals were randomly generated by a
N(120, σ2) distribution, where the mean of this normal distribution was increased by
the presence of an interaction. For example, suppose that the two-way interaction of
SNP1 and SNP2 was included in simulation. Then the mean of the random normal
distribution used to generate the phenotype was increased by 30 in the event that
an individual carried a genotypic combination such as (SNP1 = 2)(SNP2 = 2). This
example simulation model is displayed in equation 4.3. In the factorial simulation
study, we varied the standard deviation, σ of the normal distribution used to generate
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phenotypes as well. See table 2.1 for the particular variations considered in this
factorial simulation study. Each training and testing data set contained phenotypes
and SNP states for 1000 simulated subjects.
Yi = 120 + 30(I[SNP1i = 2]I[SNP2i = 2]) + εi, εi
iid∼ N(0, σ2). (4.3)
For each combination of x, M , and σ2 variants, 100 independent training and
testing data sets were generated. After predictions for the phenotypes in the testing
data were made based on the training data, mean squared prediction error (MSPE)
was calculated for each testing set. The results of the simulation study are presented
in table 4.1. Note that this table is identical to table 2.2 except for the addition
of a new column called “Quad”. This column contains the average MSPEs obtained
from implementing AQMDR (with ACAS, c = .05) and using the model expressed in
equation 4.2. In all scenarios, the Quadratic AQMDR MSPEs are lower than those
produced by the five original AQMDR methods (CWAS, ACAS (.05), ACAS (.20),
HAS (.05) and HAS (.20)). The Quad MSPEs are also lower than MSPEs produced
by QMDR in all scenarios. In many scenarios, AQMDR with a quadratic model
produced results that are very close to the Oracle approach.
To further explore the distinctions between methods in the simulation study, a single
factor, within-subjects ANOVA was performed for each simulation scenario, followed
by post hoc multiple pairwise comparisons among AQMDR, Quadratic AQMDR,
QMDR and the oracle method. For simplicity, we selected ACAS (c = .05) as the
representative variation of the original AQMDR, to be compared with QMDR, the
Oracle Method, and Quadratic AQMDR (Quad). For all simulation scenarios, the
ANOVA yielded significance at α = .05 level, suggesting that there are differences
among the average MSPEs for the prediction methods. The prediction methods were
ranked according to the results from multiple pairwise comparisons. The rankings
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Table 4.1: Average MSPE over 100 independent testing data sets for two-way inter-
action simulation study (with Quadratic AQMDR included).
M x σ CWAS ACAS
(.05)
ACAS
(.20)
HAS
(.05)
HAS
(.20)
QMDR Oracle TM Quad
4 1 10 127.19 126.59 127.27 128.30 128.09 107.78 100.55 153.96 101.93
4 1 15 255.00 254.51 254.79 255.92 255.80 247.02 225.65 277.17 231.77
4 1 20 437.61 437.03 437.40 439.31 438.87 431.89 403.66 456.85 416.76
10 1 10 133.91 131.25 132.91 131.82 133.47 109.41 100.61 153.67 103.18
10 1 15 262.52 258.09 260.87 259.29 261.85 247.03 225.28 277.70 232.19
10 1 20 444.32 438.73 440.95 440.42 442.51 435.32 402.44 454.40 417.65
4 3 10 203.78 203.78 203.78 203.78 203.78 225.70 99.57 320.45 114.06
4 3 15 331.22 331.26 331.26 331.26 331.26 354.72 225.45 448.18 241.28
4 3 20 505.97 506.35 506.20 506.36 506.20 525.42 402.17 620.46 424.07
10 3 10 223.39 220.25 223.18 220.87 223.68 226.41 100.41 320.52 149.30
10 3 15 349.97 345.91 350.19 346.67 350.87 352.16 224.93 446.17 277.99
10 3 20 528.69 523.60 528.67 524.69 529.72 527.73 400.41 623.86 458.92
4 6 10 423.23 423.23 423.23 423.23 423.23 561.48 101.14 675.00 190.14
4 6 15 554.04 554.04 554.04 554.04 554.04 693.65 227.01 805.64 320.52
4 6 20 719.00 719.00 719.00 719.00 719.00 856.36 403.00 970.46 500.87
10 6 10 338.23 329.28 336.23 330.49 337.40 561.73 101.42 674.75 109.62
10 6 15 458.38 450.28 456.92 451.36 457.97 683.20 225.75 800.40 235.75
10 6 20 631.19 622.48 630.08 623.71 631.07 844.66 402.48 954.56 413.61
from multiple pairwise comparisons with a Bonferroni correction based on the total
number of comparisons (α = .05
6
) are displayed in table 4.2.
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Table 4.2: Within-subjects ANOVA with a Bonferroni correction, α = .05
6
for two-way
interaction simulation study (with Quadratic AQMDR included).
M x σ ACAS
(.05)
QMDR Oracle Quad
4 1 10 c b a a
4 1 15 d c a b
4 1 20 d c a b
10 1 10 c b a a
10 1 15 d c a b
10 1 20 c c a b
4 3 10 c d a b
4 3 15 c d a b
4 3 20 c d a b
10 3 10 c d a b
10 3 15 c d a b
10 3 20 c c a b
4 6 10 c d a b
4 6 15 c d a b
4 6 20 c d a b
10 6 10 b c a a
10 6 15 c d a b
10 6 20 c d a b
For each simulation scenario (a row in the table), prediction methods were as-
signed rankings a, b , c, etc. where a is the ranking assigned to the method with
the lowest average MSPE. Methods sharing a letter ranking were not determined to
be statistically significant in a pairwise comparison. Note that in every scenario,
Quadratic AQMDR receives a higher ranking than ACAS and QMDR, and in some
scenarios receives a ranking equivalent to that of the Oracle Method.
4.4 Simulation Results: Three-way Interactions
Recall the simulation scenarios for three-way interactions presented in chapter 3.
Again, we performed a simulation study using a factorial design in which we examined
variations of the number of SNPs to be considered (M) and the number of present
interactions (x). SNPs were generated in the same manner discussed in the previous
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section. Phenotypes for subjects were generated using a N(120, σ2) distribution. The
mean of this normal distribution was increased by 30 with the presence of a three-
way interaction. For example, suppose that an interaction between SNP1, SNP2 and
SNP3 was included in a simulation scenario. In this case, the mean of the random
normal distribution used to generate the phenotype was increased in the event that
an individual carried a genotypic combination such as (SNP1 = 2)(SNP2 = 2)(SNP3
=2). This example simulation scenario is displayed in equation 4.4. In the factorial
simulation study, we varied the standard deviation of the normal distributions used
to generate the phenotypes. See table 3.1 for the particular variations considered in
this study. Each training and testing data set contained phenotypes and SNP states
for 1000 subjects.
Yi = 120 + 30(I[SNP1i = 2]I[SNP2i = 2]I[SNP3i = 2]) + εi, εi
iid∼ N(0, σ2) (4.4)
For each combination of variants (M , x, σ), 100 independent training and testing
data sets were generated. The methods considered were the same as those described
in chapter 2, including AQMDR (ACAS and HAS with cutoffs of c = .05 and c = .20,
and CWAS), QMDR, the training mean method and the oracle method. As we
considered only three-way interactions in this simulation study, the QMDR method
was limited only to the selection of three-way interaction models. After predictions
for the phenotypes in the testing data were made based on the training data, the mean
squared prediction error (MSPE) was calculated for each testing set. The results of
the factorial simulation study are displayed in table 4.3. Each value in the table is
the average MSPE over 100 independent testing data sets. Note that this table is
identical to table 3.2 except for the addition of a new column called “Quad”. This
column contains the average MSPEs obtained from implementing AQMDR (with
ACAS, c = .05) and using the model expressed in equation 4.2. Again we see that
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in all scenarios, the Quadratic AQMDR MSPEs are lower than those produced by
the five original AQMDR methods (CWAS, ACAS (.05), ACAS (.20), HAS (.05) and
HAS (.20)). The Quad MSPEs are also lower than MSPEs produced by QMDR in
all scenarios.
Table 4.3: Average MSPE over 100 independent testing data sets for three-way in-
teraction simulation study (with Quadratic AQMDR included).
M x σ CWAS ACAS
(.05)
ACAS
(.20)
HAS
(.05)
HAS
(.20)
QMDR Oracle TM Quad
4 1 10 117.26 117.26 117.26 117.26 117.26 105.21 100.17 208.32 102.91
4 1 15 250.27 250.32 250.32 250.32 250.32 249.87 225.50 332.00 233.68
4 1 20 435.61 436.10 436.09 436.29 436.27 441.55 400.84 508.61 419.16
10 1 10 147.45 144.75 146.96 144.89 147.07 106.28 99.91 208.83 114.14
10 1 15 271.20 265.96 271.13 266.25 271.34 246.01 223.67 330.63 240.71
10 1 20 456.11 447.47 455.27 447.94 455.64 438.04 400.56 507.22 428.03
4 2 10 152.08 152.08 152.08 152.08 152.08 201.06 101.15 345.97 131.69
4 2 15 278.18 278.18 278.18 278.18 278.18 323.70 223.56 470.72 257.36
4 2 20 457.59 457.59 457.59 457.59 457.59 497.20 397.00 644.16 434.38
10 2 10 175.67 173.43 174.89 173.50 174.96 200.34 100.27 346.25 124.85
10 2 15 303.76 301.19 302.78 301.28 302.87 323.12 225.83 468.38 254.09
10 2 20 487.30 483.83 485.95 483.97 486.08 508.05 401.86 646.56 437.34
A single factor, within-subjects ANOVA was performed for each of the twelve simu-
lation scenarios, followed by post hoc multiple pairwise comparisons among AQMDR,
Quadratic AQMDR, QMDR and the oracle method. For simplicity, we selected ACAS
(c = .05) as the representative variation of the original AQMDR, to be compared with
QMDR, the Oracle Method, and Quadratic AQMDR (Quad). In each simulation sce-
nario, the ANOVA yielded significance at α = .05 level, suggesting that there are
differences among the average MSPEs for the methods. Prediction methods were
ranked according to results from multiple pairwise comparisons (with a Bonferroni
correction, α = .05
6
). These rankings are displayed in table 4.4.
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Table 4.4: Within-subjects ANOVA with a Bonferroni correction, α = .05
6
for three-
way interaction simulation study (with Quadratic AQMDR included).
M x σ ACAS
(.05)
QMDR Oracle Quad
4 1 10 d c a b
4 1 15 c c a b
4 1 20 c d a b
10 1 10 d c a b
10 1 15 d c a b
10 1 20 d c a b
4 2 10 c d a b
4 2 15 c d a b
4 2 20 c d a b
10 2 10 c d a b
10 2 15 c d a b
10 2 20 c d a b
For each simulation scenario (represented by a row in the table), prediction meth-
ods were assigned rankings a, b, c, etc. where a is the ranking assigned to the method
with the lowest average MSPE. Again, methods sharing a letter ranking were not
determined to be statistically significant in a pairwise comparison (that is, there is
no significant difference between the methods). As we saw with the simulations for
two-way interactions, the Quadratic AQMDR method performed better than ACAS
(c = .05) and QMDR. However, there were no scenarios in which Quadratic AQMDR
received a rank equivalent to that of the Oracle Method.
4.5 Simulation Results: Two-way and Three-way Interactions Combined
In chapter 3, we also examined the combination of two-way and three-way interac-
tions through a simulation study. In each simulation, we consider ten SNPs (M = 10)
and SNP states are generated using Hardy-Weinberg Equilibrium [13]. For example,
consider a SNP, call it SNPA, with two alleles, each of which take states of A or a.
We let the probability that an individual carries allele A on a single chromosome be
p = .5, and the probability that a person carries allele a on a single chromosome
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be q = .5. Then the SNP states AA and aa each have probability p2 and q2 of oc-
curring. SNP state Aa occurs with probability 2pq. In the two previous sections, p
was fixed at p = .5. As we saw in chapter 3, for the study of two and three-way
interactions combined, the value of p for each SNP is generated using a continuous
uniform distribution on (.5, .9). Phenotypes for individuals were randomly gener-
ated by a N(120, σ2) distribution, where the mean of this normal distribution was
increased by 30 with the presence of an interaction. For example, suppose that the
two-way interaction of SNP1 and SNP2 was included in simulation. Then the mean of
the random normal distribution used to generate the phenotype was increased in the
event that an individual carried a genotypic combination such as (SNP1 = 2)(SNP2
= 2). The standard deviation of this normal distribution was fixed for each scenario
in the study.
In table 4.5, the “One-way” column indicates which of the ten SNPs considered
in simulation (SNPA, SNPB,..., SNPJ) are included as a one-way interaction (main
effect). For example, if SNPJ is included as a main effect in simulation, then ”J”
appears in this column. The “Two-way” column indicates which two-way interactions
were included. For example, if the interaction between SNPA and SNPB was included
in simulation, then AB appears in this column. Similarly, the “Three-way” column
indicates which three-way interactions were included. For example, if the interaction
between SNPC, SNPD and SNPE was included in simulation, then “CDE” appears
in this column. The magnitude of all one-way, two-way and three-way interactions
included in simulation was 30. That is, the presence of an interaction in simulation
increased the mean of the random normal distribution by 30. When calculating ag-
gregated scores in the AQMDR method, the arbitrary cutoff aggregated score with
a cutoff of c = .05 was used. Further, the Simultaneous Inclusion method (see chap-
ter 3) was selected as the representative AQMDR method in this study. That is,
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Simultaneous Inclusion was used for both the original AQMDR implementation and
the Quadratic AQMDR implementation, respectively labeled “Sim.” and “Sim-Quad”
in table 4.5. Note that “Sim-Quad” data analysis model required a quadratic term
for the two-way interaction aggregated score and a quadratic term for the three-way
aggregated score. Each value in the “Sim.”, “Sim-Quad”, and “QMDR” columns in
table 4.5 is the average MSPE calculated from 100 independent testing data sets. For
discussion that follows, we have assigned a numerical value to each scenario in the first
column of table 4.5. One can see that Quadratic AQMDR yielded smaller average
MSPEs than the original AQMDR in all simulation scenarios (with the exception of
scenarios 1 and 16 in which no interactions were present). Quadratic AQMDR also
produced lower average MSPEs than QMDR in most simulation scenarios. However,
in scenarios 1-6 and 16, QMDR performed better than Quadratic AQMDR.
Table 4.6 displays the results of post hoc multiple pairwise comparisons among the
prediction methods, performed after single factor, within subjects ANOVA tests which
all yielded significance at the α = .05 significance level. The prediction methods were
ranked according to the multiple pairwise comparisons (with Bonferroni correction,
α = .05
3
), where a ranking of a is assigned to the method with the lowest MSPE.
As in previous sections, methods sharing a letter ranking were not determined to
be statistically different. Note that Quadratic AQMDR received a ranking of “a” in
nearly all scenarios, except for 1-6 and 16 as mentioned above.
The example presented in this chapter implores us to recommend model selection
as a general strategy for AQMDR. Although we saw promising empirical results in
chapters 2 and 3 of this work, these results were improved with the implementation of
the quadratic model in place of the simple linear model applied in previous chapters.
Other models, such as a piece-wise linear model may have also yielded promising
results.
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Table 4.5: Average MSPEs for two-way and three-way interactions combined (with
Quadratic AQMDR included).
No. One-
way
Two-way Three-way Sim. Sim-
Quad
QMDR
1 - - - 239.69 241.85 229.69
2 - - ABE 261.20 247.60 229.65
3 - - ABE & CDF 261.85 250.80 229.75
4 - - EFG 261.68 247.28 230.93
5 - - EFG & HIJ 258.02 242.99 229.04
6 - AB - 267.84 240.29 230.91
7 - AB ABE 301.97 279.18 311.47
8 - AB ABE & CDF 301.70 279.22 304.53
9 - AB EFG 292.28 280.61 358.02
10 - AB EFG & HIJ 288.42 277.01 358.65
11 - AB & CD - 303.04 280.28 355.12
12 - AB & CD ABE 339.34 318.10 465.36
13 - AB & CD ABE & CDF 338.14 320.09 481.86
14 - AB & CD EFG 327.28 313.96 511.12
15 - AB & CD EFG & HIJ 326.83 313.37 511.89
16 J - - 230.71 230.90 227.02
17 J - ABE 261.74 255.56 359.98
18 J - ABE & CDF 261.85 256.58 366.59
19 J - EFG 261.74 255.81 363.91
20 J - EFG & HIJ 258.51 252.98 352.67
21 J AB - 271.15 259.59 296.91
22 J AB ABE 305.91 290.42 488.95
23 J AB ABE & CDF 302.56 289.19 481.66
24 J AB EFG 295.72 286.20 482.74
25 J AB EFG & HIJ 292.92 283.20 489.47
26 J AB & CD - 305.49 290.70 451.17
27 J AB & CD ABE 341.44 328.28 635.78
28 J AB & CD ABE & CDF 340.91 327.75 651.35
29 J AB & CD EFG 330.26 319.47 646.87
30 J AB & CD EFG & HIJ 329.04 318.07 637.61
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Table 4.6: Within-subjects ANOVA with a Bonferroni correction, α = .05
3
for two-way
and three-way interactions combined (with Quadratic AQMDR included).
No. One-way Two-way Three-way Sim. Sim-
Quad
QMDR
1 - - - b b a
2 - - ABE c b a
3 - - ABE and CDF c b a
4 - - EFG c b a
5 - - EFG and HIJ c b a
6 - AB - c b a
7 - AB ABE b a c
8 - AB ABE and CDF b a c
9 - AB EFG a a b
10 - AB EFG and HIJ b a c
11 - AB and CD - b a c
12 - AB and CD ABE b a c
13 - AB and CD ABE and CDF b a c
14 - AB and CD EFG b a c
15 - AB and CD EFG and HIJ b a c
16 J - - ab b a
17 J - ABE a a b
18 J - ABE and CDF a a b
19 J - EFG a a b
20 J - EFG and HIJ a a b
21 J AB - b a c
22 J AB ABE b a c
23 J AB ABE and CDF b a c
24 J AB EFG a a b
25 J AB EFG and HIJ a a b
26 J AB and CD - b a c
27 J AB and CD ABE b a c
28 J AB and CD ABE and CDF b a c
29 J AB and CD EFG a a b
30 J AB and CD EFG and HIJ a a b
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Chapter 5
Theoretical Considerations
5.1 Theoretical Support of AQMDR with Arbitrary Cutoff Aggregated
Score: Two-way Interactions
Suppose we have the following 2 × 2 table: Assume µhigh > µlow. Y1, ..., Y4n
Table 5.1: Distribution of Y phenotypes among SNP condition combinations.
SNP2 Condition 1 SNP2 Condition 2
SNP1 Condition 1 Y1, ..., Yn
iid∼ N(µhigh, σ2) Yn+1, ..., Y2n
iid∼ N(µlow, σ2)
SNP1 Condition 2 Y2n+1, ..., Y3n
iid∼ N(µlow, σ2) Y3n+1, ..., Y4n
iid∼ N(µlow, σ2)
represent the values of some quantitative phenotype for each subject, i = 1, 2, ..., 4n.
For interpretative purposes, for SNPs with three states (AA, Aa, and aa), Condition
1 might be the combination of SNP states AA and Aa, while Condition 2 is the SNP
state aa. Alternatively, Condition 1 may be the SNP state AA, while condition 2 is
the combination of states Aa and aa. By relabeling condition 1 and condition 2, the
configuration in table 5.1 covers any situation in which the phenotype mean of one
quadrant is higher than that of the other three quadrants (under the assumption that
the other three quadrants all have the same mean).
Let p1 be the high/low classification from the AQMDR method of a 2 × 2 table
in which cell 1 (the cell in the top left) is correctly identified as “high” and the three
remaining cells are classified as “low”. See figure 5.1, in which the shaded cell is
the one categorized as “high”, and the light cells are categorized as “low”. In what
follows, we assume that AQMDR is applied to two-way interactions in which there
are four multifactor classes, rather than the nine multifactor classes we observed for
each two-way interaction in previous chapters.
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Figure 5.1: The p1 “high”/“low” configuration.
Our goal is to prove that the under the parameter state in table 5.1, the probability
that the gene-to-gene interaction of SNP1 and SNP2 is included in the AQMDR
Arbitrary Cutoff aggregated score (ACAS with fixed c > 0) and that the p1 high/low
configuration of this interaction is correctly assigned in AQMDR tends to 1 as n goes
to infinity. To simplify notation, all probability calculations in this proof are based
on the parameter state shown in table 5.1. To clarify, suppose we have the following
events:
1. Event A: the event that the gene-to-gene interaction of SNP1 and SNP2 is
included in the AQMDR arbitrary cutoff aggregated score. That is, the inter-
action receives a weight of 1.
2. Event B: the event that the p1 high/low configuration of this interaction is
correctly assigned in AQMDR.
We want to show that P (A ∩B)→ 1 as n→∞.
The proof proceeds as follows:
Without loss of generality, let c = .05. First note that P (B) = P ((Ȳ1 > Ȳ )∩ (Ȳ2 ≤
Ȳ ) ∩ (Ȳ3 ≤ Ȳ ) ∩ (Ȳ4 ≤ Ȳ )), where Ȳ is the overall mean of of Y1, Y2, ..., Y4n, and Ȳj
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for j ∈ {1, 2, 3, 4} is the mean within cell j. That is, Ȳ1 is the mean of Y1, Y2, ..., Yn,
Ȳ2 is the mean of Yn+1, Yn+2, ..., Y2n, etc. See figure 5.2.
Figure 5.2: Individual cell means.
By DeMorgan’s Law and Boole’s inequality, we have
P (A ∩B) = 1− P (Ac ∪Bc)
≥ 1− P (Ac)− P (Bc)
= 1− P (Ac)− P ((Ȳ1 ≤ Ȳ ) ∪ (Ȳ2 > Ȳ ) ∪ (Ȳ3 > Ȳ ) ∪ (Ȳ4 > Ȳ ))
≥ 1− P (Ac)− (P (Ȳ1 ≤ Ȳ ) + P (Ȳ2 > Ȳ ) + P (Ȳ3 > Ȳ ) + P (Ȳ4 > Ȳ ))
(5.1)
By the Weak Law of Large Numbers and Slutsky’s Theorem, we have the following:
1. Ȳ1
p→ µhigh, as n→∞.
2. Ȳ2
p→ µlow, Ȳ3
p→ µlow, Ȳ4
p→ µlow, as n→∞.
3. Ȳ = n(Ȳ1+Ȳ2+Ȳ3+Ȳ4)
4n
= (Ȳ1+Ȳ2+Ȳ3+Ȳ4)
4
p→ µhigh+3µlow
4
:= µ, as n→∞.
4. µ < µhigh and µ > µlow.
Thus, as n→∞, P (Ȳ1 ≤ Ȳ ) + P (Ȳ2 > Ȳ ) + P (Ȳ3 > Ȳ ) + P (Ȳ4 > Ȳ )→ 0.
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This leaves only the consideration of P (Ac). Recall that in AQMDR with ACAS,
the inclusion of a gene-to-gene interaction in the aggregated score is based on a p-value
determined from permutation testing (see chapter 2). When c = .05, an interaction is
assigned a weight of 1 in the aggregated score if the permutation p-value associated
with that interaction is less than .05. Our goal is to show that, with probability
approaching 1 as n → ∞, the p-value achieved by permutation for the T-statistic
corresponding to this interaction is less than .05. That is, the probability that the
interaction is included in the aggregated score tends to 1 as n→∞. By establishing
this, we can then determine that P (Ac) → 0 as n → ∞. We will prove this with
a series of corollaries. Then, by the expression in (5.1), we will have shown that
P (A ∩B)→ 1 as n→∞.
First note that (disregarding 0 probability events) there are 14 possible“high”/“low”
configurations (labeling of quadrants as “high” or “low”) which can be assigned to a
2 × 2 table with AQMDR. Let them be indexed by p = 1, 2, ..., 14. See figure 5.3,
in which shaded cells are categorized as “high” and the light cells are categorized as
“low”.
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Figure 5.3: 14 possible “high”/“low” configurations.
We will define ci(p) for each p ∈ {1, 2, ..., 14}, as shown in table 5.2. Note that for
all p ∈ {1, 2, ..., 14},
∑4n
i=1 ci(p) = 0. Define T (p) for each p ∈ {1, ..., 14} as follows:
Table 5.2: ci(p) for each p ∈ {1, 2, ..., 14}.
p i ∈ {1, ..., n} i ∈ {n+ 1, ..., 2n} i ∈ {2n+ 1, ..., 3n} i ∈ {3n+ 1, ..., 4n}
1 3 -1 -1 -1
2 -1 3 -1 -1
3 -1 -1 3 -1
4 -1 -1 -1 3
5 1 1 -1 -1
6 1 -1 1 -1
7 -1 1 -1 1
8 -1 -1 1 1
9 1 -1 -1 1
10 -1 1 1 -1
11 1 1 1 -3
12 -3 1 1 1
13 1 -3 1 1
14 1 1 -3 1
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T (p) :=
4n∑
i=1
ci(p)Yi√
4n∑
i=1
ci(p)2
.
Note that for any p with one cell categorized as “high” and three cells categorized as
“low”, or one cell categorized as “low” and three cells categorized as “high”,
4n∑
i=1
ci(p)
2 =
n∑
i=1
(3)2 +
3n∑
i=1
(−1)2 = 12n.
This includes p ∈ {1, 2, 3, 4, 11, 12, 13, 14}. For all other values of p,
4n∑
i=1
ci(p)
2 =
2n∑
i=1
(1)2 +
2n∑
i=1
(−1)2 = 4n.
Corollary 1: T (p) ∼ N(kn(p)(µhigh − µlow), σ2), for a constant kn(p).
Proof: There are six cases we will consider for the distribution of T (p).
Case 1: One cell is classified as “high”, and the “high” cell is cell 1. That is, p = 1.
Consider T(1).
T (1) =
4n∑
i=1
ci(1)Yi
√
12n
=
n∑
i=1
(3)Yi +
4n∑
i=n+1
(−1)Yi
√
12n
=
3nȲhigh − 3nȲlow√
12n
=
3n(Ȳhigh − Ȳlow)√
12n
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where Ȳhigh is a sample mean of realized values of Yi from a cell with mean µhigh (cell
1), and Ȳlow is a sample mean of realized values of Yi from cells with mean µlow (cells
2, 3, and 4). As
∑4n
i=1 ci(1) = 0,
T (1) ∼ N
(
kn(1)(µhigh − µlow), σ2
)
where kn(1) =
3n√
12n
=
(
3n
4
)1/2
.
Case 2: One cell is classified as “high”, and the “high” cell is not cell 1. That is,
p ∈ {2, 3, 4}.
Consider T(2).
T (2) =
4n∑
i=1
ci(2)Yi
√
12n
=
n∑
i=1
(−1)Yi +
2n∑
i=n+1
(3)Yi +
4n∑
i=2n+1
(−1)Yi
√
12n
=
−nȲhigh + 3nȲlow − 2nȲlow√
12n
As
4n∑
i=1
ci(2) = 0,
T (2) ∼ N
(
(−nµhigh + 3nµlow − 2nµlow)√
12n
, σ2
)
= N
(
kn(2) (µhigh − µlow) , σ2
)
where kn(2) =
−n√
12n
= −
(
n
12
)1/2
. The same is true for T (3) and T (4).
Case 3: Two cells are classified as “high”, and one of the “high” cells is cell 1. That
is, p ∈ {5, 6, 9}.
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Consider T(5).
T (5) =
4n∑
i=1
ci(5)Yi
√
4n
=
2n∑
i=1
(1)Yi +
2n∑
i=n+1
(1)Yi +
4n∑
i=2n+1
(−1)Yi
√
4n
=
nȲhigh + nȲlow − 2nȲlow√
4n
As
4n∑
i=1
ci(5) = 0,
T (5) ∼ N
(
(nµhigh + nµlow − 2nµlow)√
4n
, σ2
)
= N
(
kn(5) (µhigh − µlow) , σ2
)
where kn(5) =
n√
4n
=
(
n
4
)1/2
. The same is true for T (6) and T (9).
Case 4: Two cells are classified as “high”, but cell 1 is classified as “low”. That
is, p ∈ {7, 8, 10}.
Consider T(7).
T (7) =
4n∑
i=1
ci(7)Yi
√
4n
=
n∑
i=1
(−1)Yi +
2n∑
i=n+1
(1)Yi +
3n∑
i=2n+1
(−1)Yi +
4n∑
i=3n+1
(1)Yi
√
4n
=
−nȲhigh + nȲlow − nȲlow + nȲlow√
4n
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As
4n∑
i=1
ci(7) = 0,
T (7) ∼ N
(
(−nµhigh + nµlow − nµlow + nµlow)√
4n
, σ2
)
= N
(
kn(7) (µhigh − µlow) , σ2
)
where kn(7) =
−n√
4n
= −
(
n
4
)1/2
. The same is true for T (8) and T (10).
Case 5: Three cells are classified as “high”, one of which is cell 1. That is, p ∈
{11, 13, 14}.
Consider T(11).
T (11) =
4n∑
i=1
ci(11)Yi
√
12n
=
n∑
i=1
(1)Yi +
2n∑
i=n+1
(1)Yi +
3n∑
i=2n+1
(1)Yi +
4n∑
i=3n+1
(−3)Yi
√
12n
=
nȲhigh + nȲlow + nȲlow − 3nȲlow√
12n
As
4n∑
i=1
ci(11) = 0,
T (11) ∼ N
(
(nµhigh + nµlow + nµlow − 3nµlow)√
12n
, σ2
)
= N
(
kn(11) (µhigh − µlow) , σ2
)
where kn(11) =
n√
12n
=
(
n
12
)1/2
. The same is true for T (13) and T (14).
Case 6: Three cells are classified as “high”, but cell 1 is classified as “low”. That
is, p = 12.
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Consider T(12).
T (12) =
4n∑
i=1
ci(12)Yi
√
12n
=
n∑
i=1
(−3)Yi +
4n∑
i=n+1
(1)Yi
√
12n
=
−3nȲhigh + 3nȲlow√
12n
As
4n∑
i=1
ci(12) = 0,
T (12) ∼ N
(
(−3nµhigh + 3nµlow)√
12n
, σ2
)
= N
(
kn(12) (µhigh − µlow) , σ2
)
where kn(12) =
−3n√
12n
= −
(
3n
4
)1/2
.
In summary, T (p) ∼ N(kn(p)(µhigh−µlow), σ2), for a constant kn(p). The values of
kn(p) for each p are displayed in table 5.3. Note that kn(1) = max1≤p≤14kn(p). Thus
Table 5.3: kn(p) for each p ∈ {1, 2, ..., 14}.
p kn(p) p kn(p)
1
(
3n
4
)1/2
8 −
(
n
4
)1/2
2 −
(
n
12
)1/2
9
(
n
4
)1/2
3 −
(
n
12
)1/2
10 −
(
n
4
)1/2
4 −
(
n
12
)1/2
11
(
n
12
)1/2
5
(
n
4
)1/2
12 −
(
3n
4
)1/2
6
(
n
4
)1/2
13
(
n
12
)1/2
7 −
(
n
4
)1/2
14
(
n
12
)1/2
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we have proved Corollary 1. Now, define a T-statistic as follows:
T := max1≤p≤14T (p)
This T-statistic is not quite identical to the one used in AQMDR (see equation 2.1)
because sample variances are not incorporated. We forgo the estimation of the vari-
ances because we assume that Y1, ..., Y4n all have the same underlying variance. Let
δ be an arbitrary small positive number. Assume n is large enough such that
(kn(1)−max2≤p≤14kn(p))(µhigh − µlow) ≥
2σ
δ
(5.2)
That is, [(3n
4
)1/2 − (n
4
)1/2](µhigh − µlow) ≥ 2σδ .
Corollary 2: P (T = T (1)) ≥ 1− 13δ2.
Proof: Put µdiff := µhigh − µlow. Note that E[T (p) − T (1)] = (kn(p) − kn(1))µdiff
and V ar[T (p)− T (1)] ≤ 4σ2. By Chebychev’s Inequality, for all p ∈ {1, 2, ..., 14} we
have
P
(
|T (p)− T (1) + (kn(1)− kn(p))µdiff | ≥
2σ
δ
)
≤ δ2 (5.3)
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For any p ∈ {2, 3, ..., 14},
P (T (p) > T (1)) = P (T (p)− T (1) ≥ 0)
= P (T (p)− T (1) + (kn(1)− kn(p)) (µdiff ) ≥ (kn(1)− kn(p))µdiff )
≤ P
(
T (p)− T (1) + (kn(1)− kn(p)) (µdiff ) ≥
2σ
δ
)
by (5.2),
≤ P
(
|T (p)− T (1) + (kn(1)− kn(p)) (µdiff ) | ≥
2σ
δ
)
≤ δ2 by the inequality expressed in (5.3).
Now, consider P (T 6= T (1)). By Boole’s inequality, we have
P (T 6= T (1)) = P (T (1) 6= max1≤p≤14T (p))
= P ((T (2) > T (1)) ∪ (T (3) > T (1)) ∪ ... ∪ (T (14) > T (1)))
≤ P (T (2) > T (1)) + P (T (3) > T (1)) + ...+ P (T (14) > T (1))
≤ 13δ2
Hence,
P (T = T (1)) ≥ 1− 13δ2 (5.4)
and we have proved Corollary 2. Note that since T (p) is normally distributed, this
bound is not sharp.
Consider a fixed permutation π : {1, 2, ..., 4n} → {1, 2, ..., 4n}. Define Tπ(p) as
follows:
Tπ(p) :=
4n∑
i=1
cπ(i)(p)Yπ(i)√
4n∑
i=1
cπ(i)(p)2
=
4n∑
i=1
cπ(i)(p)Yπ(i)√
4n∑
i=1
ci(p)2
Define the test statistic for permutation π as follows:
Tπ := max1≤p≤14Tπ(p)
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Corollary 3: For all p ∈ {1, 2, ..., 14}:
Tπ(p) ∼ N(kπn(p)(µdiff ), σ2)
where kπn(p) depends upon π only through Xp, where Xp is the number of phenotypes
which were originally in cell 1 that remained in a “high” cell after permutation.
Proof: Let C = {1, 2, ..., n}. We will consider 3 cases for the distribution of Tπ(p).
Case 1: p ∈ {1, 2, 3, 4}
For p configurations in which one cell is categorized as “high”, and three are cat-
egorized as “low” (p ∈ {1, 2, 3, 4}), we define D to be the set of π(i)’s correspond-
ing to the cell categorized as “high” in the p configuration. For example, if p = 1,
D = {π(1), ..., π(n)}, and if p = 2, D = {π(n + 1), ..., π(2n)}. Let Xp = |C ∩ D|.
That is, Xp is the number of phenotypes which were originally in cell 1, that remained
in a cell classified as “high” after permutation. For all p ∈ {1, 2, 3, 4}, we have the
following:
1. |C ∩Dc| = n−Xp
2. |Cc ∩D| = n−Xp
3. |Cc ∩Dc| = 4n−Xp − (n−Xp)− (n−Xp) = 2n+Xp
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Consider Tπ(p):
Tπ(p) =
4n∑
i=1
cπ(i)(p)Yπ(i)√
4n∑
i=1
ci(p)2
=
4n∑
i=1
cπ(i)(p)Yπ(i)
√
12n
=
∑
C∩D
(3)Yπ(i) +
∑
Cc∩D
(3)Yπ(i) +
∑
C∩Dc
(−1)Yπ(i) +
∑
Cc∩Dc
(−1)Yπ(i)
√
12n
=
3XpȲhigh + 3(n−Xp)Ȳlow − (n−Xp)Ȳhigh − (2n+Xp)Ȳlow√
12n
Thus,
Tπ(p) ∼ N
(
3Xpµhigh + (3n− 3Xp)µlow − (n−Xp)µhigh − (2n+Xp)µlow√
12n
, σ2
)
= N
(
(4Xp − n) (µdiff )√
12n
, σ2
)
That is, Tπ(p) ∼ N(kπn(p)(µdiff ), σ2) where kπn(p) =
4Xp−n√
12n
depends on π only through
Xp.
Case 2: p ∈ {5, 6, 7, 8, 9, 10}
For p configurations in which two cells are categorized as “high”, and two are cat-
egorized as “low” (p ∈ {5, 6, 7, 8, 9, 10}), we define D to be the set of π(i)’s corre-
sponding to cells categorized as “high” in the p configuration. For example, if p = 5,
D = {π(1), ..., π(2n)}, and if p = 6, D = {π(1), ..., π(n)}∪{π(2n+ 1), ..., π(3n)}. Let
Xp = |C ∩D|. For all p ∈ {5, 6, 7, 8, 9, 10}, we have the following:
1. |C ∩Dc| = n−Xp
2. |Cc ∩D| = 2n−Xp
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3. |Cc ∩Dc| = 4n−Xp − (2n−Xp)− (n−Xp) = n+Xp
For p ∈ {5, 6, 7, 8, 9, 10}, we have
Tπ(p) =
4n∑
i=1
cπ(i)(p)Yπ(i)√
4n∑
i=1
ci(p)2
=
4n∑
i=1
cπ(i)(p)Yπ(i)
√
4n
=
∑
C∩D
(1)Yπ(i) +
∑
Cc∩D
(1)Yπ(i) +
∑
C∩Dc
(−1)Yπ(i) +
∑
Cc∩Dc
(−1)Yπ(i)
√
4n
=
XpȲhigh + (2n−Xp)Ȳlow − (n−Xp)Ȳhigh − (n+Xp)Ȳlow√
4n
Thus,
Tπ(p) ∼ N
(
Xpµhigh + (2n−Xp)µlow − (n−Xp)µhigh − (n+Xp)µlow√
4n
, σ2
)
= N
(
(2Xp − n) (µdiff )√
4n
, σ2
)
That is, Tπ(p) ∼ N(kπn(p)(µdiff ), σ2) where kπn(p) =
2Xp−n√
4n
depends on π only through
Xp.
Case 3: p ∈ {11, 12, 13, 14}
For p configurations where 3 cells are categorized as “high”, and 1 is categorized
as “low” (p ∈ {11, 12, 13, 14}), we define D to be the set of π(i)’s corresponding
to cells categorized as “high” in the p configuration. For example, if p = 11, D =
{π(1), ..., π(3n)}. Let Xp = |C ∩D|. For p ∈ {11, 12, 13, 14}, we have the following:
1. |C ∩Dc| = n−Xp
2. |Cc ∩D| = 3n−Xp
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3. |Cc ∩Dc| = 4n−Xp − (3n−Xp)− (n−Xp) = Xp
For p ∈ {11, 12, 13, 14}, we have
Tπ(p) =
4n∑
i=1
cπ(i)(p)Yπ(i)√
4n∑
i=1
ci(p)2
=
4n∑
i=1
cπ(i)(p)Yπ(i)
√
12n
=
∑
C∩D
(1)Yπ(i) +
∑
Cc∩D
(1)Yπ(i) +
∑
C∩Dc
(−3)Yπ(i) +
∑
Cc∩Dc
(−3)Yπ(i)
√
12n
=
XpȲhigh + (3n−Xp)Ȳlow + (−3n+ 3Xp)Ȳhigh − 3(Xp)Ȳlow√
12n
Thus,
Tπ(p) ∼ N
(
Xpµhigh + (3n−Xp)µlow + (−3n− 3Xp)µhigh − (3Xp)µlow√
12n
, σ2
)
= N
(
(4Xp − 3n) (µdiff )√
12n
, σ2
)
That is, Tπ(p) ∼ N(kπn(p)(µdiff ), σ2) where kπn(p) =
4Xp−3n√
12n
depends on π only through
Xp.
Thus, we have the following general result for all p ∈ {1, 2, ..., 14}:
Tπ(p) ∼ N(kπn(p)(µdiff ), σ2)
where kπn(p) depends upon π only through Xp. Thus, we have proved Corollary 3.
By Chebychev’s inequality,
P
(
Tπ(p)− kπn(p)(µdiff ) ≥
σ
δ
)
≤ P
(
|Tπ(p)− kπn(p)(µdiff )| ≥
σ
δ
)
≤ δ2 (5.5)
66
Assume (kn(1)− kπn(p)) (µdiff ) ≥ 2σδ . Then we have
P (T (1) < Tπ(p)) = P (Tπ(p)− T (1) ≥ 0)
= P (Tπ(p)− T (1) + (kn(1)− kπn(p))µdiff ≥ (kn(1)− kπn(p))µdiff )
≤ P (|Tπ(p)− T (1) + (kn(1)− kπn(p))µdiff | ≥ (kn(1)− kπn(p))µdiff )
≤ P
(
|Tπ(p)− T (1) + (kn(1)− kπn(p))µdiff | ≥
2σ
δ
)
≤ P (|Tπ(p)− kπn(p)µdiff |+ |T (1)− kn(1)µdiff | ≥
2σ
δ
)
by the triangle inequality.
Note that {|Tπ(p)−kπn(p)µdiff |+ |T (1)−kn(1)µdiff | ≥ 2σδ } ⊆ {(|Tπ(p)−k
π
n(p)µdiff | ≥
σ
δ
) ∪ (|T (1)− kn(1)µdiff | ≥ σδ )}. Thus,
P (T (1) < Tπ(p)) ≤ P (|Tπ(p)− kπn(p)µdiff |+ |T (1)− kn(1)µdiff | ≥
2σ
δ
)
≤ P (|Tπ(p)− kπn(p)µdiff | ≥
σ
δ
) + P (|T (1)− kn(1)µdiff | ≥
σ
δ
)
≤ 2δ2
Thus, by Boole’s inequality we have for any fixed permutation π such that (kn(1) −
kπn(p))(µdiff ) ≥ 2σδ , for 1 ≤ p ≤ 14,
P (T (1) < Tπ) = P ((T (1) < Tπ(1)) ∪ (T (1) < Tπ(2)) ∪ ... ∪ (T (1) < Tπ(14)))
≤ P (T (1) < Tπ(1)) + P (T (1) < Tπ(2)) + ...+ P (T (1) < Tπ(14))
≤ 2δ2 + 2δ2 + ...+ 2δ2
= 28δ2
(5.6)
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Hence, we have
P (T < Tπ|T = T (1)) ≤
P (T (1) < Tπ)
P (T = T (1))
≤ 28δ
2
1− 13δ2
by (5.4) and (5.6)
This gives us
P (T ≥ Tπ|T = T (1)) ≥ 1−
28δ2
1− 13δ2
=
1− 41δ2
1− 13δ2
≥ 1− 41δ2
(5.7)
Now we impose a discrete uniform distribution on all permutations. For all p ∈
{1, 2, ..., 14}, this imposes a hypergeometric distribution on Xp. This follows because
we can think of Xp as the number of “successes” (that is, the number of phenotypes
which were originally in cell 1 that remained in a “high” cell in configuration p after
permutation) in K draws from a finite population of size 4n which contains n possible
“successes”. In particular, K is determined by the number of cells classified as “high”
in the p configuration after permutation. For example, if p = 1, K = n, but if p = 5,
K = 2n. Let Ap be a subset of the support of Xp, Supp(Xp) such that x ∈ Ap implies
that (kn(1)− kπn(p))(µdiff ) ≥ 2σδ .
Corollary 4: P (Xp ∈ Ap) ≥ 1− δ2 for all p.
Proof: Again, we will consider three cases.
Case 1: p ∈ {1, 2, 3, 4}
In this case, K = n. By known formulas for moments of a hypergeometric distri-
bution, E[Xp] =
n
4
and V ar[Xp] =
9n2
16(4n−1) .
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Thus, by Chebychev’s Inequality we have
P (Xp /∈ Ap) = P
(
(kn(1)− kπn(p))(µdiff ) ≤
2σ
δ
)
= P
((
3n
4
)1/2
− 4Xp − n√
12n
≤ 2σ
δµdiff
)
= P
(
4Xp − n√
12n
≥ − 2σ
δµdiff
+
(
3n
4
)1/2)
≤
(
9n2
12n(4n− 1)
)(
12nµ2diff
(−2σ
√
12n+ 3nδµdiff )2
)
δ2
≤ δ2 for sufficiently large n
Thus, P (Xp ∈ Ap) ≥ 1− δ2 for sufficiently large n.
Case 2: p ∈ {5, 6, 7, 8, 9, 10}
In this case, K = 2n. By known formulas for moments of a hypergeometric dis-
tribution, E[Xp] =
n
2
and V ar[Xp] =
3n2
4(4n−1) . Thus, by Chebychev’s Inequality we
have
P (Xp /∈ Ap) = P
(
(kn(1)− kπn(p))(µdiff ) ≤
2σ
δ
)
= P
((
3n
4
)1/2
− 2Xp − n√
4n
≤ 2σ
δµdiff
)
= P
(
2Xp − n√
4n
≥ − 2σ
δµdiff
+
(
3n
4
)1/2)
≤
(
3n2
4n(4n− 1)
)(
12nµ2diff
(−2σ
√
12n+ 3nδµdiff )2
)
δ2
≤ δ2 for sufficiently large n
Thus, P (Xp ∈ Ap) ≥ 1− δ2 for sufficiently large n.
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Case 3: p ∈ {11, 12, 13, 14}
In this case, K = 3n. By known formulas for moments of a hypergeometric dis-
tribution, E[Xp] =
3n
4
and V ar[Xp] =
9n2
16(4n−1) .
Thus, by Chebychev’s Inequality we have
P (Xp /∈ Ap) = P
(
(kn(1)− kπn(p))(µdiff ) ≤
2σ
δ
)
= P
((
3n
4
)1/2
− 4Xp − 3n√
12n
≤ 2σ
δµdiff
)
= P
(
4Xp − 3n√
12n
≥ − 2σ
δµdiff
+
(
3n
4
)1/2)
≤
(
9n2
12n(4n− 1)
)(
12nµ2diff
(−2σ
√
12n+ 3nδµdiff )2
)
δ2
≤ δ2 for sufficiently large n
Thus, P (Xp ∈ Ap) ≥ 1− δ2 for sufficiently large n.
This yields the following general result: Let Ap be a subset of Supp(Xp) such that
x ∈ Ap implies (kn(1) − kπn(p))(µdiff ) ≥ 2σδ . For sufficiently large n, we have
P (Xp ∈ Ap) ≥ 1 − δ2 for all 1 ≤ p ≤ 14, and we have proved Corollary 4. By
Boole’s inequality we have the following:
P (Xp ∈ Ap∀p ∈ {1, 2, ..., 14}) = P ((X1 ∈ A1) ∩ (X2 ∈ A2) ∩ ... ∩ (X14 ∈ A14))
= 1− P ((X1 /∈ A1) ∪ (X2 /∈ A2) ∪ ... ∪ (X14 /∈ A14))
≥ 1− P (X1 /∈ A1)− P (X2 /∈ A2) ...− P (X14 /∈ A14)
≥ 1− 14δ2
(5.8)
By independence we have P (Xp ∈ Ap∀p|T = T (1)) = P (Xp ∈ Ap∀p). Thus, by the
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law of total probability we have
P (T > Tπ|T = T (1)) = P (T > Tπ|Xp ∈ Ap∀p, T = T (1))P (Xp ∈ Ap∀p|T = T (1))
+ P (T > Tπ|Xp /∈ Ap∀p, T = T (1))P (Xp /∈ Ap∀p|T = T (1))
≥ P (T > Tπ|Xp ∈ Ap∀p, T = T (1))P (Xp ∈ Ap∀p|T = T (1))
= P (T > Tπ|Xp ∈ Ap∀p, T = T (1))P (Xp ∈ Ap∀p)
≥ (1− 41δ2)(1− 14δ2) by (5.7) and (5.8)
= 1− 55δ2 + (14)(41)δ4
≥ 1− 55δ2
(5.9)
As δ can be chosen arbitrarily, this yields P (T > Tπ|T = T (1))→ 1 as n→∞. Thus,
we have
P (T > Tπ) = P (T > Tπ|T = T (1))P (T = T (1)) + P (T > Tπ|T 6= T (1))P (T 6= T (1))
≥ P (T > Tπ|T = T (1))P (T = T (1))
≥ (1− 55δ2)(1− 13δ2) by (5.4) and (5.9)
= 1− 68δ2 + (55)(13)δ4
≥ 1− 68δ2
(5.10)
As δ can be chosen arbitrarily, this yields P (T > Tπ)→ 1 as n→∞. Thus, for 1000
randomly selected permutations, {π1, π2..., π1000}, the probability that T > Tπi for at
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least 951 of the πi’s (i.e., that the permutation p-value is less than .05) is
P (T > Tπi for at least 951 of the πi’s) ≥ P (T > Tπi for 1000 of the πi’s)
≥ (1− 68δ2)1000 by (5.10)
= 1− ε
where for every ε > 0, δ can be chosen such that
δ =
√
1− (1− ε) 11000
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Thus, the probability that the permutation p-value is less than .05 must also tend to
1 as n→∞. Returning to the beginning of the proof, we have shown that P (A)→ 1
as n → ∞, implying that P (Ac) tends to 0 as n tends to infinity. Thus, by the
expression in (5.1), we have shown P (A ∩ B) → 1 as n → ∞. Note that this result
still holds for any arbitrary value chosen for c, instead of c = .05.
5.2 Analogous Theoretical Results for Three-way Interactions
Consider the three-way interaction among three SNPs: SNPA, SNPB and SNPC .
As in the previous section, suppose each of these SNPs carry two states, condition 1
and condition 2. For illustration, assign labels to each of the SNP states as follows:
• A1 := SNPA, condition 1
• A2 := SNPA, condition 2
• B1 := SNPB, condition 1
• B2 := SNPB, condition 2
• C1 := SNPC , condition 1
• C2 := SNPC , condition 2
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This three-way interaction is represented by the cube at the top of figure 5.4. Each
multifactor class (cell) is represented by one of the eight smaller cubes, illustrated
at the bottom of the figure. We assign labels to these multifactor classes (1-8) as
shown in figure 5.4. Suppose i = 1, 2, ..., n correspond to subjects in cell 1, i =
Figure 5.4: Illustration of the three-way interaction between SNPA, SNPB, SNPC
n + 1, n + 2, ..., 2n correspond to subjects in cell 2, and so forth. Let Y1, ..., Y8n
represent the values of some quantitative phenotype for each subject, i = 1, 2, ..., 8n.
Let Y1, ..., Yn
iid∼ N(µhigh, σ2) and Yn+1, ..., Y8n
iid∼ N(µlow, σ2), where µhigh > µlow.
Let p1 be the high/low classification from the AQMDR method of a three-way in-
teraction in which cell 1 is correctly identified as “high” and the seven remaining cells
are classified as “low”. See figure 5.5, in which the shaded cell is the one categorized
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as “high”, and the light cells are categorized as “low”. In what follows, we assume
that AQMDR is applied to three-way interactions in which there are eight multi-
factor classes, rather than the 27 multifactor classes we observed for each three-way
interaction in previous chapters.
Figure 5.5: The p1 “high”/“low” configuration.
Once again, our goal is to prove that the probability that the gene-to-gene in-
teraction of SNPA, SNPB and SNPC is included in the AQMDR Arbitrary Cutoff
aggregated score (ACAS with fixed c > 0) and that the p1 high/low configuration of
this interaction is correctly assigned in AQMDR tends to 1 as n goes to infinity. We
will do so with an argument that is analogous to that of the previous section. We
have the following events:
1. Event A: the event that the three-way gene-to-gene interaction of SNPA, SNPB
and SNPC is included in the AQMDR arbitrary cutoff aggregated score. That
is, the interaction receives a weight of 1.
2. Event B: the event that the p1 high/low configuration of this interaction is
correctly assigned in AQMDR.
We want to show that P (A ∩B)→ 1 as n→∞.
The proof proceeds as follows:
74
Without loss of generality, let c = .05. First note that P (B) = P ((Ȳ1 > Ȳ )∩ (Ȳ2 ≤
Ȳ )∩ (Ȳ3 ≤ Ȳ )∩ (Ȳ4 ≤ Ȳ )∩ (Ȳ5 ≤ Ȳ )∩ (Ȳ6 ≤ Ȳ )∩ (Ȳ7 ≤ Ȳ )∩ (Ȳ8 ≤ Ȳ )), where Ȳ is
the overall mean of Y1, Y2, ..., Y8n, and Ȳj for j ∈ {1, ..., 8} is the mean within cell j.
That is, Ȳ1 is the mean of Y1, Y2, ..., Yn, Ȳ2 is the mean of Yn+1, Yn+2, ..., Y2n, etc. By
DeMorgan’s Law and Boole’s inequality, we have
P (A ∩B) = 1− P (Ac ∪Bc)
≥ 1− P (Ac)− P (Bc)
= 1− P (Ac)− P ((Ȳ1 ≤ Ȳ ) ∪ (Ȳ2 > Ȳ ) ∪ (Ȳ3 > Ȳ ) ∪ (Ȳ4 > Ȳ ) ∪ (Ȳ5 > Ȳ )
∪ (Ȳ6 > Ȳ ) ∪ (Ȳ7 > Ȳ ) ∪ (Ȳ8 > Ȳ ))
≥ 1− P (Ac)− (P (Ȳ1 ≤ Ȳ ) + P (Ȳ2 > Ȳ ) + P (Ȳ3 > Ȳ ) + P (Ȳ4 > Ȳ )
+ (Ȳ5 > Ȳ ) + (Ȳ6 > Ȳ ) + (Ȳ7 > Ȳ ) + (Ȳ8 > Ȳ ))
(5.11)
By the Weak Law of Large Numbers and Slutsky’s Theorem, we have the following:
1. Ȳ1
p→ µhigh, as n→∞.
2. Ȳ2, Ȳ3, Ȳ4, Ȳ5, Ȳ6, Ȳ7, Ȳ8
p→ µlow, as n→∞.
3. Ȳ = n(Ȳ1+Ȳ2+Ȳ3+Ȳ4+Ȳ5+Ȳ6+Ȳ7+Ȳ8)
8n
= Ȳ1+Ȳ2+Ȳ3+Ȳ4+Ȳ5+Ȳ6+Ȳ7+Ȳ8
8
p→ µhigh+7µlow
8
:= µ,
as n→∞.
4. µ < µhigh and µ > µlow.
Thus, as n → ∞, P (Ȳ1 ≤ Ȳ ) + P (Ȳ2 > Ȳ ) + P (Ȳ3 > Ȳ ) + P (Ȳ4 > Ȳ ) + P (Ȳ5 >
Ȳ ) + P (Ȳ6 > Ȳ ) + P (Ȳ7 > Ȳ ) + P (Ȳ8 > Ȳ )→ 0.
This leaves only the consideration of P (Ac). Recall that in AQMDR with ACAS,
the inclusion of a gene-to-gene interaction in the aggregated score is based on a p-value
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determined from permutation testing (see chapter 2). When c = .05, an interaction is
assigned a weight of 1 in the aggregated score if the permutation p-value associated
with that interaction is less than .05. Our goal is to show that, with probability
approaching 1 as n → ∞, the p-value achieved by permutation for the T-statistic
corresponding to this interaction is less than .05. That is, the probability that the
interaction is included in the aggregated score tends to 1 as n→∞. By establishing
this, we can then determine that P (Ac) → 0 as n → ∞. We will prove this with
a series of corollaries. Then, by the expression in (5.11), we will have shown that
P (A ∩B)→ 1 as n→∞.
First note that (disregarding 0 probability events) there are 254 possible“high”/“low”
configurations (labeling of cells as “high” or “low”) which can be assigned to a three-
way interaction with AQMDR. Denote these configurations as p = 1, ..., 254. All
possible configurations can be categorized into one of 14 configuration cases. Let Pj
represent the group of p’s in configuration case j for j ∈ {1, ..., 14}. These configura-
tion cases are described in the following table.
Table 5.4: Description of configuration cases.
j Case Description
1 One cell is labeled “high” and that cell is cell 1.
2 Two cells are labeled “high”, one of which is cell 1.
3 Three cells are labeled “high”, one of which is cell 1.
4 Four cells are labeled “high”, one of which is cell 1.
5 Five cells are labeled “high”, one of which is cell 1.
6 Six cells are labeled “high”, one of which is cell 1.
7 Seven cells are labeled “high”, one of which is cell 1.
8 One cell is labeled “high” and that cell is not cell 1.
9 Two cells are labeled “high”, neither of which are cell 1.
10 Three cells are labeled “high”, none of which are cell 1.
11 Four cells are labeled “high”, none of which are cell 1.
12 Five cells are labeled “high”, none of which are cell 1.
13 Six cells are labeled “high”, none of which are cell 1.
14 Seven cells are labeled “high”, none of which are cell 1.
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We will define ci(p) for each p ∈ {1, 2, ..., 254} such that
∑8n
i=1 ci(p) = 0. The ci(p)
definitions for representative examples of p’s within each configuration case Pj for
j ∈ {1, 2, ..., 14} are shown in table 5.5.
Table 5.5: ci(p) for representative examples of p’s within each configuration case Pj
for j ∈ {1, 2, ..., 14}.
j cell 1 cell 2 cell 3 cell 4 cell 5 cell 6 cell 7 cell 8
1 7 -1 -1 -1 -1 -1 -1 -1
2 3 3 -1 -1 -1 -1 -1 -1
3 5 5 5 -3 -3 -3 -3 -3
4 1 1 1 1 -1 -1 -1 -1
5 3 3 3 3 3 -5 -5 -5
6 1 1 1 1 1 1 -3 -3
7 1 1 1 1 1 1 1 -7
8 -1 7 -1 -1 -1 -1 -1 -1
9 -1 3 3 -1 -1 -1 -1 -1
10 -3 5 5 5 -3 -3 -3 -3
11 -1 1 1 1 1 -1 -1 -1
12 -5 3 3 3 3 3 -5 -5
13 -3 1 1 1 1 1 1 -3
14 -7 1 1 1 1 1 1 1
Define T (p) for each p = 1, ..., 254 as follows:
T (p) :=
8n∑
i=1
ci(p)Yi√
8n∑
i=1
ci(p)2
.
Corollary 1: T (p) ∼ N(kn(p)(µhigh − µlow), σ2), for a constant kn(p).
Proof: There are 14 cases we will consider for the distribution of T (p) (one for each
configuration case Pj).
Case 1: p ∈ P1
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There is only one configuration in P1, so let’s call this configuration p = 1.
T (1) =
8n∑
i=1
ci(1)Yi
√
56n
=
n∑
i=1
(7)Yi +
8n∑
i=n+1
(−1)Yi
√
56n
=
7nȲhigh − 7nȲlow√
56n
=
7n(Ȳhigh − Ȳlow)√
56n
where Ȳhigh is a sample mean of realized values of Yi from a cell with mean µhigh (cell
1), and Ȳlow is a sample mean of realized values of Yi from cells with mean µlow (cells
2, 3,...,8). As
∑8n
i=1 ci(1) = 0,
T (1) ∼ N
(
kn(1)(µhigh − µlow), σ2
)
where kn(1) =
7n√
56n
=
(
7n
8
)1/2
.
Case 2: p ∈ P2.
T (p) =
8n∑
i=1
ci(p)Yi
√
24n
=
n∑
i=1
(3)Yi +
2n∑
i=n+1
(3)Yi +
8n∑
i=2n+1
(−1)Yi
√
24n
=
3nȲhigh + 3nȲlow − 6nȲlow√
24n
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As
8n∑
i=1
ci(2) = 0,
T (p) ∼ N
(
(3nµhigh + 3nµlow − 6nµlow)√
24n
, σ2
)
= N
(
kn(p) (µhigh − µlow) , σ2
)
where kn(p) =
3n√
24n
=
(
3n
8
)1/2
for p ∈ P2.
The 12 remaining cases can be considered using similar calculations. In summary,
T (p) ∼ N(kn(p)(µhigh−µlow), σ2), for a constant kn(p). Thus, we have proved Corol-
lary 1. The values of kn(p) for each configuration case are displayed in table 5.6. Note
that kn(1) = max1≤p≤254kn(p). Now, define a T-statistic as follows:
Table 5.6: kn(p)
p kn(p) p kn(p)
p = 1
(
7n
8
)1/2
p ∈ P8 −
(
n
56
)1/2
p ∈ P2
(
3n
8
)1/2
p ∈ P9 −
(
n
24
)1/2
p ∈ P3
(
5n
24
)1/2
p ∈ P10 −
(
3n
40
)1/2
p ∈ P4
(
n
8
)1/2
p ∈ P11 −
(
n
8
)1/2
p ∈ P5
(
3n
40
)1/2
p ∈ P12 −
(
5n
24
)1/2
p ∈ P6
(
n
24
)1/2
p ∈ P13 −
(
3n
8
)1/2
p ∈ P7
(
n
56
)1/2
p ∈ P14 −
(
7n
8
)1/2
T := max1≤p≤254T (p).
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This T-statistic is not quite identical to the one used in AQMDR (see equation 2.1)
because sample variances are not incorporated. We forgo the estimation of the vari-
ances because we assume that Y1, ..., Y8n all have the same underlying variance. Let
δ be an arbitrary small positive number. Assume n is large enough such that
(kn(1)−max2≤p≤254kn(p))(µhigh − µlow) ≥
2σ
δ
(5.12)
That is, [(7n
8
)1/2 − (3n
8
)1/2](µhigh − µlow) ≥ 2σδ .
Corollary 2: P (T = T (1)) ≥ 1− 253δ2.
Proof: Put µdiff := µhigh − µlow. Note that E[T (p) − T (1)] = (kn(p) − kn(1))µdiff
and V ar[T (p)− T (1)] ≤ 4σ2. By Chebychev’s Inequality, for all p ∈ {1, 2, ..., 254} we
have
P
(
|T (p)− T (1) + (kn(1)− kn(p))µdiff | ≥
2σ
δ
)
≤ δ2 (5.13)
For any p ∈ {2, 3, ..., 254},
P (T (p) > T (1)) = P (T (p)− T (1) ≥ 0)
= P (T (p)− T (1) + (kn(1)− kn(p))µdiff ≥ (kn(1)− kn(p))µdiff )
≤ P
(
T (p)− T (1) + (kn(1)− kn(p))µdiff ≥
2σ
δ
)
by (5.12),
≤ P
(
|T (p)− T (1) + (kn(1)− kn(p))µdiff | ≥
2σ
δ
)
≤ δ2 by (5.13).
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Now, consider P (T 6= T (1)). By Boole’s inequality, we have
P (T 6= T (1)) = P (T (1) 6= max1≤p≤254T (p))
= P ((T (2) > T (1)) ∪ (T (3) > T (1)) ∪ ... ∪ (T (254) > T (1)))
≤ P (T (2) > T (1)) + P (T (3) > T (1)) + ...+ P (T (254) > T (1))
≤ 253δ2
Hence,
P (T = T (1)) ≥ 1− 253δ2 (5.14)
and we have proved Corollary 2.
Consider a fixed permutation π : {1, 2, ..., 8n} → {1, 2, ..., 8n}. Define Tπ(p) as
follows:
Tπ(p) :=
8n∑
i=1
cπ(i)(p)Yπ(i)√
8n∑
i=1
cπ(i)(p)2
=
8n∑
i=1
cπ(i)(p)Yπ(i)√
8n∑
i=1
ci(p)2
.
Define the test statistic for permutation π as follows:
Tπ := max1≤p≤254Tπ(p).
Corollary 3: For all p:
Tπ(p) ∼ N(kπn(p)(µdiff ), σ2)
where kπn(p) depends upon π only through Xp, where Xp is the number of phenotypes
which were originally in a cell 1 that remained in a “high” cell after permutation..
Proof: Let C = {1, 2, ..., n}. We will consider 7 cases for the distribution of Tπ(p).
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Case 1: Cases in which one cell is labeled “high”, including p = 1 and p ∈ P8.
We define D to be the set of π(i)’s corresponding to the cell categorized as “high”
in the p configuration. For example, if p = 1, D = {π(1), ..., π(n)}. Let Xp = |C∩D|.
That is, Xp is the number of phenotypes which were originally in cell 1, that remained
in a cell classified as “high” after permutation. For all p ∈ ({1} ∪ P8), we have the
following:
1. |C ∩Dc| = n−Xp
2. |Cc ∩D| = n−Xp
3. |Cc ∩Dc| = 8n−Xp − (n−Xp)− (n−Xp) = 6n+Xp
Consider Tπ(p):
Tπ(p) =
8n∑
i=1
cπ(i)(p)Yπ(i)√
8n∑
i=1
ci(p)2
=
8n∑
i=1
cπ(i)(p)Yπ(i)
√
56n
=
∑
C∩D
(7)Yπ(i) +
∑
Cc∩D
(7)Yπ(i) +
∑
C∩Dc
(−1)Yπ(i) +
∑
Cc∩Dc
(−1)Yπ(i)
√
56n
=
7XpȲhigh + 7(n−Xp)Ȳlow − (n−Xp)Ȳhigh − (6n+Xp)Ȳlow√
56n
Thus,
Tπ(p) ∼ N
(
7Xpµhigh + (7n− 7Xp)µlow − (n−Xp)µhigh − (6n+Xp)µlow√
56n
, σ2
)
= N
(
(8Xp − n) (µdiff )√
56n
, σ2
)
That is, Tπ(p) ∼ N(kπn(p)(µdiff ), σ2) where kπn(p) =
8Xp−n√
56n
depends on π only through
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Xp.
Case 2: Cases in which two cells are labeled “high”, including p ∈ (P2 ∪ P9).
We define D to be the set of π(i)’s corresponding to the cell categorized as “high”
in the p configuration. Let Xp = |C ∩D|. We have the following:
1. |C ∩Dc| = n−Xp
2. |Cc ∩D| = 2n−Xp
3. |Cc ∩Dc| = 8n−Xp − (2n−Xp)− (n−Xp) = 5n+Xp
For p ∈ (P2 ∪ P9), we have
Tπ(p) =
8n∑
i=1
cπ(i)(p)Yπ(i)√
8n∑
i=1
ci(p)2
=
8n∑
i=1
cπ(i)(p)Yπ(i)
√
24n
=
∑
C∩D
(3)Yπ(i) +
∑
Cc∩D
(3)Yπ(i) +
∑
C∩Dc
(−1)Yπ(i) +
∑
Cc∩Dc
(−1)Yπ(i)
√
24n
=
3XpȲhigh + 3(2n−Xp)Ȳlow − (n−Xp)Ȳhigh − (5n+Xp)Ȳlow√
24n
Thus,
Tπ(p) ∼ N
(
3Xpµhigh + (6n− 3Xp)µlow − (n−Xp)µhigh − (5n+Xp)µlow√
24n
, σ2
)
= N
(
(4Xp − n) (µdiff )√
24n
, σ2
)
That is, Tπ(p) ∼ N(kπn(p)(µdiff ), σ2) where kπn(p) =
4Xp−n√
24n
depends on π only through
Xp.
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The remaining cases can be considered using similar calculations. We have the fol-
lowing general result for all p ∈ {1, 2, ..., 254}:
Tπ(p) ∼ N(kπn(p)(µdiff ), σ2)
where kπn(p) depends upon π only through Xp. Thus we have proved Corollary 3. The
kπn(p)’s for each of the 7 cases are displayed in the following table.
Table 5.7: kπn(p)
p kπn(p)
p ∈ ({1} ∪ P8) 8Xp−n√56n
p ∈ (P2 ∪ P9) 4Xp−n√24n
p ∈ (P3 ∪ P10) 8Xp−3n√120n
p ∈ (P4 ∪ P11) 2Xp−n√8n
p ∈ (P5 ∪ P12) 8Xp−5n√120n
p ∈ (P6 ∪ P13) 4Xp−3n√24n
p ∈ (P7 ∪ P14) 8Xp−7n√56n
By Chebychev’s inequality,
P
(
Tπ(p)− kπn(p)µdiff ≥
σ
δ
)
≤ P
(
|Tπ(p)− kπn(p)µdiff | ≥
σ
δ
)
≤ δ2 (5.15)
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Assume (kn(1)− kπn(p))µdiff ≥ 2σδ . Then we have
P (T (1) < Tπ(p)) = P (Tπ(p)− T (1) ≥ 0)
= P (Tπ(p)− T (1) + (kn(1)− kπn(p))µdiff ≥ (kn(1)− kπn(p))µdiff )
≤ P (|Tπ(p)− T (1) + (kn(1)− kπn(p))µdiff | ≥ (kn(1)− kπn(p))µdiff )
≤ P
(
|Tπ(p)− T (1) + (kn(1)− kπn(p))µdiff | ≥
2σ
δ
)
≤ P (|Tπ(p)− kπn(p)µdiff |+ |T (1)− kn(1)µdiff | ≥
2σ
δ
)
by the triangle inequality.
Note that {|Tπ(p)−kπn(p)µdiff |+ |T (1)−kn(1)µdiff | ≥ 2σδ } ⊆ {(|Tπ(p)−k
π
n(p)µdiff | ≥
σ
δ
) ∪ (|T (1)− kn(1)µdiff | ≥ σδ )}. Thus,
P (T (1) < Tπ(p)) ≤ P (|Tπ(p)− kπn(p)µdiff |+ |T (1)− kn(1)µdiff | ≥
2σ
δ
)
≤ P (|Tπ(p)− kπn(p)µdiff | ≥
σ
δ
) + P (|T (1)− kn(1)µdiff | ≥
σ
δ
)
≤ 2δ2
Thus, by Boole’s inequality we have for any fixed permutation π such that (kn(1) −
kπn(p))(µdiff ) ≥ 2σδ , for 1 ≤ p ≤ 254,
P (T (1) < Tπ) = P ((T (1) < Tπ(1)) ∪ (T (1) < Tπ(2)) ∪ ... ∪ (T (1) < Tπ(254)))
≤ P (T (1) < Tπ(1)) + P (T (1) < Tπ(2)) + ...+ P (T (1) < Tπ(254))
≤ 2δ2 + 2δ2 + ...+ 2δ2
= 508δ2.
(5.16)
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Hence, we have
P (T < Tπ|T = T (1)) ≤
P (T (1) < Tπ)
P (T = T (1))
≤ 508δ
2
1− 253δ2
by (5.14) and (5.16).
For any fixed permutation π such that (kn(1)− kπn(p))(µdiff ) ≥ 2σδ , for 1 ≤ p ≤ 254,
P (T ≥ Tπ|T = T (1)) ≥ 1−
508δ2
1− 253δ2
=
1− 761δ2
1− 253δ2
≥ 1− 761δ2.
(5.17)
Now we impose a discrete uniform distribution on all permutations. For all p ∈
{1, 2, ..., 254}, this imposes a hypergeometric distribution on Xp. This follows because
we can think of Xp as the number of “successes” (that is, the number of phenotypes
which were originally in cell 1 that remained in a “high” cell in configuration p after
permutation) in K draws from a finite population of size 8n which contains n possible
“successes”. In particular, K is determined by the number of cells classified as “high”
in the p configuration after permutation. For example, if p = 1, K = n, but if p ∈ P2,
K = 2n. Let Ap be a subset of the support of Xp, Supp(Xp) such that x ∈ Ap implies
that (kn(1)− kπn(p))(µdiff ) ≥ 2σδ .
Corollary 4: P (Xp /∈ Ap) ≥ 1− δ2 for all p.
Proof: Again, we will consider seven cases.
Case 1: p ∈ ({1} ∪ P8)
In this case, K = n. By known formulas for moments of a hypergeometric distri-
bution, E[Xp] =
n
8
and V ar[Xp] =
49n2
64(8n−1) .
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Thus, by Chebychev’s Inequality we have
P (Xp /∈ Ap) = P
(
(kn(1)− kπn(p))(µdiff ) ≤
2σ
δ
)
= P
((
7n
8
)1/2
− 8Xp − n√
56n
≤ 2σ
δµdiff
)
= P
(
8Xp − n√
56n
≥ − 2σ
δµdiff
+
(
7n
8
)1/2)
≤
(
49n2
56n(8n− 1)
)(
56nµ2diff
(−2σ
√
56n+ 7nδµdiff )2
)
δ2
≤ δ2 for sufficiently large n
Thus, P (Xp ∈ Ap) ≥ 1− δ2 for sufficiently large n.
Case 2: p ∈ (P2 ∪ P9)
In this case, K = 2n. By known formulas for moments of a hypergeometric dis-
tribution, E[Xp] =
n
4
and V ar[Xp] =
21n2
16(8n−1) . Thus, by Chebychev’s Inequality we
have
P (Xp /∈ Ap) = P
(
(kn(1)− kπn(p))(µdiff ) ≤
2σ
δ
)
= P
((
7n
8
)1/2
− 4Xp − n√
24n
≤ 2σ
δµdiff
)
= P
(
4Xp − n√
24n
≥ − 2σ
δµdiff
+
(
7n
8
)1/2)
≤
(
21n2
24n(8n− 1)
)(
56nµ2diff
(−2σ
√
56n+ 7nδµdiff )2
)
δ2
≤ δ2 for sufficiently large n
Thus, P (Xp ∈ Ap) ≥ 1− δ2 for sufficiently large n.
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Case 3: p ∈ (P3 ∪ P10)
In this case, K = 3n. By known formulas for moments of a hypergeometric dis-
tribution, E[Xp] =
3n
8
and V ar[Xp] =
105n2
64(8n−1) . Thus, by Chebychev’s Inequality we
have
P (Xp /∈ Ap) = P
(
(kn(1)− kπn(p))(µdiff ) ≤
2σ
δ
)
= P
((
7n
8
)1/2
− 8Xp − 3n√
120n
≤ 2σ
δµdiff
)
= P
(
8Xp − 3n√
120n
≥ − 2σ
δµdiff
+
(
7n
8
)1/2)
≤
(
105n2
120n(8n− 1)
)(
56nµ2diff
(−2σ
√
56n+ 7nδµdiff )2
)
δ2
≤ δ2 for sufficiently large n
Thus, P (Xp ∈ Ap) ≥ 1− δ2 for sufficiently large n.
Case 4: p ∈ (P4 ∪ P11)
In this case, K = 4n. By known formulas for moments of a hypergeometric dis-
tribution, E[Xp] =
n
2
and V ar[Xp] =
7n2
4(8n−1) . Thus, by Chebychev’s Inequality we
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have
P (Xp /∈ Ap) = P
(
(kn(1)− kπn(p))(µdiff ) ≤
2σ
δ
)
= P
((
7n
8
)1/2
− 2Xp − n√
8n
≤ 2σ
δµdiff
)
= P
(
2Xp − n√
8n
≥ − 2σ
δµdiff
+
(
7n
8
)1/2)
≤
(
7n2
8n(8n− 1)
)(
56nµ2diff
(−2σ
√
56n+ 7nδµdiff )2
)
δ2
≤ δ2 for sufficiently large n
Thus, P (Xp ∈ Ap) ≥ 1− δ2 for sufficiently large n.
Case 5: p ∈ (P5 ∪ P12)
In this case, K = 5n. By known formulas for moments of a hypergeometric dis-
tribution, E[Xp] =
5n
8
and V ar[Xp] =
105n2
64(8n−1) . Thus, by Chebychev’s Inequality we
have
P (Xp /∈ Ap) = P
(
(kn(1)− kπn(p))(µdiff ) ≤
2σ
δ
)
= P
((
7n
8
)1/2
− 8Xp − 5n√
120n
≤ 2σ
δµdiff
)
= P
(
8Xp − 5n√
120n
≥ − 2σ
δµdiff
+
(
7n
8
)1/2)
≤
(
105n2
120n(8n− 1)
)(
56nµ2diff
(−2σ
√
56n+ 7nδµdiff )2
)
δ2
≤ δ2 for sufficiently large n
Thus, P (Xp ∈ Ap) ≥ 1− δ2 for sufficiently large n.
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Case 6: p ∈ (P6 ∪ P13)
In this case, K = 6n. By known formulas for moments of a hypergeometric dis-
tribution, E[Xp] =
3n
4
and V ar[Xp] =
21n2
16(8n−1) . Thus, by Chebychev’s Inequality we
have
P (Xp /∈ Ap) = P
(
(kn(1)− kπn(p))(µdiff ) ≤
2σ
δ
)
= P
((
7n
8
)1/2
− 4Xp − 3n√
24n
≤ 2σ
δµdiff
)
= P
(
4Xp − 3n√
24n
≥ − 2σ
δµdiff
+
(
7n
8
)1/2)
≤
(
21n2
24n(8n− 1)
)(
56nµ2diff
(−2σ
√
56n+ 7nδµdiff )2
)
δ2
≤ δ2 for sufficiently large n
Thus, P (Xp ∈ Ap) ≥ 1− δ2 for sufficiently large n.
Case 7: p ∈ (P7 ∪ P14)
In this case, K = 7n. By known formulas for moments of a hypergeometric dis-
tribution, E[Xp] =
7n
8
and V ar[Xp] =
49n2
64(8n−1) . Thus, by Chebychev’s Inequality we
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have
P (Xp /∈ Ap) = P
(
(kn(1)− kπn(p))(µdiff ) ≤
2σ
δ
)
= P
((
7n
8
)1/2
− 8Xp − 7n√
56n
≤ 2σ
δµdiff
)
= P
(
8Xp − 7n√
56n
≥ − 2σ
δµdiff
+
(
7n
8
)1/2)
≤
(
49n2
56n(8n− 1)
)(
56nµ2diff
(−2σ
√
56n+ 7nδµdiff )2
)
δ2
≤ δ2 for sufficiently large n
Thus, P (Xp ∈ Ap) ≥ 1− δ2 for sufficiently large n.
This yields the following general result: Let Ap be a subset of Supp(Xp) such that
x ∈ Ap implies (kn(1) − kπn(p))(µdiff ) ≥ 2σδ . For sufficiently large n, we have
P (Xp ∈ Ap) ≥ 1 − δ2 for all 1 ≤ p ≤ 254. Thus we have proved Corollary 4.
By Boole’s inequality we have the following:
P (Xp ∈ Ap∀p ∈ {1, 2, ..., 254}) = P ((X1 ∈ A1) ∩ (X2 ∈ A2) ∩ ... ∩ (X254 ∈ A254))
= 1− P ((X1 /∈ A1) ∪ (X2 /∈ A2) ∪ ... ∪ (X254 /∈ A254))
≥ 1− P (X1 /∈ A1)− P (X2 /∈ A2) ...− P (X254 /∈ A254)
≥ 1− 254δ2
(5.18)
By independence we have P (Xp ∈ Ap∀p|T = T (1)) = P (Xp ∈ Ap∀p). Thus, by the
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law of total probability we have
P (T > Tπ|T = T (1)) = P ((T > Tπ|Xp ∈ Ap∀p, T = T (1))P (Xp ∈ Ap∀p|T = T (1))
+ P ((T > Tπ|Xp /∈ Ap∀p, T = T (1))P (Xp /∈ Ap∀p|T = T (1))
≥ P ((T > Tπ|Xp ∈ Ap∀p, T = T (1))P (Xp ∈ Ap∀p|T = T (1))
= P ((T > Tπ|Xp ∈ Ap∀p, T = T (1))P (Xp ∈ Ap∀p)
≥ (1− 761δ2)(1− 254δ2) by (5.17) and (5.18)
= 1− 1015δ2 + (761)(254)δ4
≥ 1− 1015δ2
(5.19)
As δ can be chosen arbitrarily, this yields P (T > Tπ|T = T (1))→ 1 as n→∞. Thus,
we have
P (T > Tπ) = P (T > Tπ|T = T (1))P (T = T (1)) + P (T > Tπ|T 6= T (1))P (T 6= T (1))
≥ P (T > Tπ|T = T (1))P (T = T (1))
≥ (1− 1015δ2)(1− 253δ2) by (5.14) and (5.19)
= 1− 1268δ2 + (1268)(253)δ4
≥ 1− 1268δ2
(5.20)
As δ can be chosen arbitrarily, this yields P (T > Tπ)→ 1 as n→∞. Thus, for 1000
randomly selected permutations, {π1, π2..., π1000}, the probability that T > Tπi for at
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least 951 of the πi’s (i.e., that the permutation p-value is less than .05) is
P (T > Tπi for at least 951 of the πi’s) ≥ P (T > Tπi for 1000 of the πi’s)
≥ (1− 1268δ2)1000 by (5.20)
= 1− ε
where for every ε > 0, δ can be chosen such that
δ =
√
1− (1− ε) 11000
1268
Thus, the probability that the permutation p-value is less than .05 must also tend to
1 as n→∞. Returning to the beginning of the proof, we have shown that P (A)→ 1
as n → ∞, implying that P (Ac) tends to 0 as n tends to infinity. Thus, by the
expression in (5.11), we have shown P (A ∩ B)→ 1 as n→∞. Note that this result
still holds for any arbitrary value chosen for c, instead of c = .05.
5.3 Theoretical Considerations for Present and Non-present Two-way
and Three-way Interactions
Suppose we have ten SNPs, SNPA, SNPB, ..., SNPJ , and are interested in four
independent interactions:
1. SNPA × SNPB
2. SNPC × SNPD × SNPE
3. SNPF × SNPG
4. SNPH × SNPI × SNPJ
Suppose each of the ten SNPs carry two states, condition 1 and condition 2. For
illustration, assign labels to each of the SNP states as shown in table 5.8. Suppose
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Table 5.8: Labels for the SNP states.
A1 := SNPA, condition 1 A2 := SNPA, condition 2
B1 := SNPB, condition 1 B2 := SNPB, condition 2
C1 := SNPC , condition 1 C2 := SNPC , condition 2
D1 := SNPD, condition 1 D2 := SNPD, condition 2
E1 := SNPE, condition 1 E2 := SNPE, condition 2
F1 := SNPF , condition 1 F2 := SNPF , condition 2
G1 := SNPG, condition 1 G2 := SNPG, condition 2
H1 := SNPH , condition 1 H2 := SNPH , condition 2
I1 := SNPI , condition 1 I2 := SNPI , condition 2
J1 := SNPJ , condition 1 J2 := SNPJ , condition 2
we have 8n subjects, and let Y1, ..., Y8n represent the values of some quantitative
phenotype for each subject, i = 1, 2, ..., 8n. Assume that subjects are distributed
evenly among multifactor classes within interactions. That is, each multifactor cell
within a two-way interaction contains 2n subjects, and each multifactor cell within a
three-way interaction contains n subjects. Further, suppose that the SNPA × SNPB
interaction and the SNPC × SNPD × SNPE interaction are present and that the
remaining two interactions are not. That is,
Yi = µ0 + µ1(A1i)(B1i) + µ2(C1i)(D1i)(E1i) + εi (5.21)
where ε
iid∼ N(0, σ2) and µ1, µ2 > 0. Note that some loss of generality occurs with the
µ1, µ2 > 0 assumption. Figure 5.6 illustrates the four interactions. Here, the shaded
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Figure 5.6: Illustration of the four interactions to be considered.
multifactor cells represent genotypic combinations for which the phenotype mean is
increased by the presence of an interaction.
Regarding the arbitrary cutoff aggregated score (ACAS) with c = .05, we will show
the following propositions:
1. P (SNPA × SNPB is included in the aggregated score) → 1, n→∞.
2. P (SNPC × SNPD × SNPE is included in the aggregated score) → 1, n→∞.
3. P (SNPF × SNPG is included in the aggregated score) ≤ .05
4. P (SNPH × SNPI × SNPJ is included in the aggregated score) ≤ .05
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The proofs proceed as follows:
Proposition 1: P (SNPA × SNPB is included in the aggregated score) → 1,
n→∞.
To show this, we refer back to section 5.1. If we let µhigh = µ0 + µ1 +
1
8
µ2 and
adjust for a doubled sample size, the proof for proposition follows from the sequence
in which we proved that P (A)→ 1, n→∞ in section 4.1.
Proposition 2: P (SNPC × SNPD × SNPE is included in the aggregated score)
→ 1, n→∞.
To show this, we refer back to section 5.2. If we let µhigh = µ0 + µ2 +
1
4
µ1,
the proof of this proposition follows from the sequence in which we proved that
P (A)→ 1, n→∞ in section 4.2.
Proposition 3: P (SNPF × SNPG is included in the aggregated score) ≤ .05
As illustrated in section 5.1, there are there are 14 possible “high”/“low” configu-
rations (labeling of quadrants as “high” or “low”) which can be assigned to a 2 × 2
table with AQMDR. Let them be indexed by p = 1, 2, ..., 14. See figure 5.3. Again,
we define ci(p) for each p = {1, 2, ..., 14}, as shown in table 5.2. Define T (p) for each
p ∈ {1, ..., 14} as follows:
T (p) :=
8n∑
i=1
ci(p)Yi√
8n∑
i=1
ci(p)2
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Consider T(1).
T (1) =
8n∑
i=1
ci(1)Yi
√
24n
=
2n∑
i=1
(3)Yi +
8n∑
i=2n+1
(−1)Yi
√
24n
=
6nȲ1 − 6nȲ2√
24n
=
6n(Ȳ1 − Ȳ2)√
24n
where Ȳ1 is a sample mean of realized values of Yi for i ∈ {1, ..., 2n}, and Ȳ2 is a
sample mean of Yi for i ∈ {2n + 1, ..., 8n} (all of which have mean µ0 + 14µ1 +
1
8
µ2).
As
∑8n
i=1 ci(1) = 0,
T (1) ∼ N
(
0, σ2
)
.
A series of similar calculations yield the following general result for all p ∈ {1, ..., 14}:
T (p) ∼ N
(
0, σ2
)
.
Define a T-statistic as follows:
T := max1≤p≤14T (p).
Consider a fixed permutation π : {1, 2, ..., 8n} → {1, 2, ..., 8n}. Define Tπ(p) as
follows:
Tπ(p) :=
8n∑
i=1
cπ(i)(p)Yπ(i)√
8n∑
i=1
cπ(i)(p)2
=
8n∑
i=1
cπ(i)(p)Yπ(i)√
8n∑
i=1
ci(p)2
.
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Define the test statistic for permutation π as follows:
Tπ := max1≤p≤14Tπ(p).
As T and Tπ are functions of the Yi’s, let’s call them T (Y) and Tπ(Y) where
Y =

Y1
.
.
.
Y8n

.
Now, suppose we have 1000 permutations π1, π2, ..., π1000, and these correspond to
Tπ1(Y), Tπ2(Y), ..., Tπ1000(Y). It is obvious that if we were to sort the set T (Y),
Tπ1(Y),..., Tπ1000(Y) from lowest to highest, the ordering would be random. That is,
T (Y) is equally likely to be between any two of the Tπi(Y)’s for i ∈ {1, ..., 1000}.
Let Ai be I[T (Y) < Tπi(Y)]. Then
1000∑
j=1
Aj is equal to the number of Tπi(Y)’s on the
right side of T (Y) in the ordering mentioned above. Because this ordering is random,
1000∑
j=1
Aj ∼ Unif(0, 1000). In order for this interaction to be included in the arbitrary
cutoff aggregated score with c = .05, less than 50 of 1000 independent permutations
of the Yi’s should produce Tπ’s that are greater than T . That is,
1000∑
j=1
Aj ≤ 50. Based
on the uniform distribution of
1000∑
j=1
Aj, P (the interaction is included in the aggregated
score) = P (
1000∑
j=1
Aj < 50) < .05.
Proposition 4: P (SNPH × SNPI × SNPJ is included in the aggregated score)
≤ .05 The proof of this proposition is analogous to that of Proposition 3.
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Chapter 6
Application: Exploring Interactions Between APOE and Known
Alzheimer’s Disease Associated SNPs
6.1 Introduction
Alzheimer’s disease (AD) is a devastating neurodegenerative disorder that is char-
acterized by impairment in memory and decreased cognition [14]. AD is progressive in
nature, typically beginning with mild loss of memory but often leading to difficulties
with communication, loss of ability to respond to surroundings and loss of autonomy
[15]. AD is the most common form of dementia worldwide, affecting more than 24
million people [14]. Forecasts suggest that by 2050, Alzheimer’s disease will affect 1
out 85 people. In the United States alone, an estimated 5 million people are currently
diagnosed with AD, and this number is expected to increase to about 14 million by
2050 [16].
The criteria for diagnosis of AD established by the National Institute on Aging
and Alzheimer’s Association are dispersed between two categories. The first category
includes core clinical criteria, which can be assessed by physicians without the need
for advanced imaging equipment or cerebrospinal fluid analysis. The second category
includes research criteria, which involve the use of biomarkers based on imaging and
measures from cerebrospinal fluid [17]. For this research we focus on biomarkers that
directly reflect the pathology of AD by providing evidence of the presence of proteins
deposited in the brain during the course of AD, such as the amyloid-beta protein (Aβ)
and tau. Research suggests that build up of these two proteins in the brain may be
a mark of AD. A low measure of Aβ in cerebrospinal fluid (CSF) serves as a marker
of Aβ deposition in the brain. Similarly, a high level of tau or phosphorylated-tau
(p-tau) in CSF serves as a marker of tau accumulation in the brain [17].
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In addition to these CSF biomarkers, genetic influences on AD risk have also been
identified. The most notable of these is the apolipoprotein E (APOE ) gene [17]. In
humans, the APOE gene exists in three polymorphic alleles: ε2, ε3, and ε4. Genome-
wide association studies (GWAS) suggest that ε4 is the strongest genetic risk factor
for AD. In the overall population, ε4 occurs in 13.7% of people, but among AD
patients this frequency is increased to 40% [18]. In fact, research has shown that the
ε4 allele of the APOE gene (APOE4 ) carries a two-to-three fold increase in AD risk
for individuals with one ε4 allele, and a 12-fold increase in risk for those with two ε4
alleles [19].
Previous studies have identified SNPs with known main effect associations with
Alzheimer’s disease status. Lambert et al. [20] analyzed 7,055,881 SNPs as main
effects, and found that 19 SNPs were associated with AD. Some of these susceptibil-
ity loci had previously been identified in similar studies (from the ABCA7, APOE,
BIN1, CLU, CR1, CD2AP, EPHA1, MS4A6A, and PICALM genes), but several
susceptibility loci were newly-identified in the study. These loci are found on the
following genes: HLA, PTK2B, SORL1, SLC24A4, DSG2, INPP5D, MEF2C, NME8,
ZCWPW1, CELF1, FERMT2, and CASS4 [20]. Although CD33 was not identified
by the Lambert et al. study as an AD susceptibility gene, Griciuc et al. produced
results which suggest that CD33 may play a role in reducing Alzheimer’s risk by pre-
venting diminishing Aβ in cerebrospinal fluid [21]. Similarly, MAPT (which encodes
for CSF tau) has been identified as a possible susceptibility gene for AD [22], as well
as Presenilin E318G [23] and TREM2 [24]. Based on these studies, a set of 23 known
AD associated SNPs (in addition to APOE4 count) were selected for this study, and
are displayed in table 6.1 [20, 23, 24, 21]. Note that these SNPs each take values of
0, 1, or 2.
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Table 6.1: SNPs considered in this study.
Chromosome SNP Position Gene
1 rs6656401 207518704 CR1
2 rs6733839 127135234 BIN1
2 rs35349669 233159830 INPP5D
5 rs190982 88927603 MEF2C
6 rs75932628 41161514 TREM2
6 rs10948363 47520026 CD2AP
7 rs2718058 37801932 NME8
7 rs1476679 100406823 ZCWPW1
7 rs11771145 143413669 EPHA1
8 rs28834970 27337604 PTK2B
8 rs9331896 27610169 CLU
11 rs10838725 47536319 CELF1
11 rs983392 60156035 MS4A6A
11 rs10792832 86156833 PICALM
11 rs11218343 121564878 SORL1
14 rs17125944 52933911 FERMT2
14 rs17125721 73206470 PSEN1
14 rs10498633 92460608 SLC24A4
17 rs8070723 46003698 MAPT
18 rs8093731 31508995 DSG2
19 rs4147929 1063444 ABCA7
19 rs3865444 51224706 CD33
20 rs7274581 56443204 CASS4
In this study, we aimed to identify gene-to-gene interactions that demonstrated
association with counts of tau and Aβ found in cerebrospinal fluid, while restricting
ourselves to only those two-way and three-way interactions including APOE4. We ap-
plied the Aggregated Quantitative Multifactor Dimensionality Reduction (AQMDR)
method proposed in this work to exhaustively search for significant interactions and
aggregate them into two predictors (one aggregated score for two-way interactions,
and one for three-way interactions). We also applied the Quantitative Multifactor
Dimensionality Reduction (QMDR) technique, which resulted in candidate two-way
and three-way interactions, and selected an optimal interaction between the two can-
didates. We then evaluated the resulting AQMDR and QMDR models by providing
a training data R2 for each method.
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6.2 Methods
Data for this study were obtained from the Alzheimer’s Disease Neuroimaging Ini-
tiative (ADNI). The ADNI study is a longitudinal study conducted in multiple North
American sites in which participants are assessed clinically, and genetic and biomarker
information is recorded for these individuals throughout the aging process [25]. The
sample data set for this application study included observations from 419 individuals
for whom baseline measures of CSF tau and CSF Aβ were available. 253 of these
subjects were female and 166 subjects were male. The subjects ranged in age from
54 to 89, with an average age of 74.51. About 28% of the subjects were classified as
normal controls (N) regarding disease status, about 48% were diagnosed with mild
cognitive impairment (MCI), and 24% were diagnosed with mild Alzheimer’s disease
(AD).
We restricted attention to gene-to-gene interactions which included APOE4. That
is, we considered 23 two-way interactions (APOE4 with each of the SNPs listed in
table 6.1) and
(
23
2
)
three-way interactions. These interactions were evaluated for
association with two quantitative outcome variables, CSF Aβ and CSF tau. Each of
these outcome variables were considered separately using the following analysis steps:
1. Subjects were stratified based on disease status (N, MCI or AD), and a separate
analysis was performed for each stratification group. The rationale for this
stratification stems from the fact that the three disease strata represent three
vastly different populations.
2. To control for common AD covariates [26], the quantitative outcome variables
were regressed on gender, age, and education and the residuals were used as the
new quantitative outcome variable of interest.
3. We applied the Aggregated Quantitative Multifactor Dimensionality Reduction
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(AQMDR) method to these subsets of interactions and recorded the permu-
tation p-values obtained for each interaction. Note that the sample data had
missing values, which were excluded in this initial application study. That is, for
each interaction, only subjects with observations for all SNP factors involved in
the interaction were included in the analysis. For each interaction, the main ef-
fects for involved SNPs were incorporated in a regression model for the outcome
variable, and then residuals of this model were used as the outcome variable for
the AQMDR analysis.
4. The permutation p-values were then used to develop an aggregated score for
two-way interactions and an aggregated score for three-way interactions. These
aggregated scores were developed using the Arbitrary Cutoff Aggregated Score
(ACAS) with c = .10. Note that lower values for c were initially considered, but
a higher cutoff was chosen in order to have at least one interaction included in
an aggregated score for the quantitative outcomes. Again, subjects with missing
values for SNPs which were included in the aggregated score were excluded from
the analysis.
5. We combined the aggregated scores (the two-way aggregated score and the
three-way aggregated score) in a linear regression model for the outcome using
the Simultaneous Inclusion method described in chapter 3.
6. The regression model was evaluated with a training R2.
7. To compare the proposed AQMDR method with current methodology, for each
of the outcome variables we used Quantitative Multifactor Dimensionality Re-
duction (QMDR) to select a candidate two-way interaction and a candidate
three-way interaction, and to identify an optimal interaction between the two
candidates (see chapter 1 of this work for details of the QMDR method). The
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optimal interaction was used as a predictor in a linear regression model and
evaluated with a training R2.
6.3 AQMDR Results
In the results that follow, an AQMDR permutation p-value that is less than .10 is
denoted with (*), a p-value that is less than .05 is denoted with (**). Also note that
although the interactions we consider in this study are SNP-by-SNP interactions, for
ease of interpretation, we denote each SNP by its gene name. For example, in some
of the following tables we write CR1 instead of rs6656401.
Table 6.2 displays the permutation p-values obtained in the AQMDR implemen-
tation for two-way interactions regarding CSF tau. Each row in the table represents
the two-way interaction between the given SNP and APOE4. Permutation p-values
are given for each disease status stratum (N, MCI or AD). Note that for an arbitrary
cutoff of c = .10, only one of the 23 two-way interactions is identified as significant,
APOE4 by ABCA7. Further, APOE4 by ABCA7 was only identified as significant
within the normal control (N) stratum.
Table 6.3 summarizes the significant interactions for CSF tau obtained from the
consideration of three-way interactions and the corresponding permutation p-values
obtained for the interactions in the AQMDR analysis. Note that if an interaction was
significant in any of the three disease strata, it is included in this table along with
the permutation p-values for all three strata.
Table 6.4 displays the permutation p-values obtained in the AQMDR implemen-
tation for two-way interactions regarding CSF Aβ. Again, each row in the table
represents the two-way interaction between the given SNP and APOE4. Permutation
p-values are given for each disease status stratum (N, MCI or AD). For an arbitrary
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Table 6.2: Two-way interaction permutation p-values for CSF tau.
SNP Gene N MCI AD
rs6656401 CR1 1.000 0.961 0.743
rs6733839 BIN1 0.995 0.642 0.937
rs35349669 INPP5D 0.589 0.996 0.982
rs190982 MEF2C 0.996 0.998 0.390
rs75932628 TREM2 1.000 1.000 1.000
rs10948363 CD2AP 0.921 0.964 0.593
rs2718058 NME8 1.000 1.000 0.896
rs1476679 ZCWPW1 1.000 0.993 0.691
rs11771145 EPHA1 0.950 1.000 0.641
rs28834970 PTK2B 0.337 0.940 0.895
rs9331896 CLU 0.924 0.988 0.462
rs10838725 CELF1 0.682 0.985 0.999
rs983392 MS4A6A 0.993 0.574 1.000
rs10792832 PICALM 0.402 0.759 0.872
rs11218343 SORL1 1.000 1.000 1.000
rs17125944 FERMT2 0.995 0.982 0.717
rs17125721 PSEN1 0.707 0.180 1.000
rs10498633 SLC24A4 1.000 0.896 1.000
rs8070723 MAPT 0.953 0.991 0.985
rs8093731 DSG2 1.000 0.388 0.981
rs4147929 ABCA7 0.084* 0.792 0.984
rs3865444 CD33 1.000 0.877 0.891
rs7274581 CASS4 0.883 1.000 0.636
cutoff of c = .10, only one interaction is identified as significant, APOE4 by PTK2B.
Further, APOE4 by PTK2B was only significant in disease stratum MCI.
Table 6.5 summarizes the significant interactions for CSF Aβ obtained from the
consideration of three-way interactions and the corresponding permutation p-values
obtained for the interactions in the AQMDR analysis. Note that if an interaction was
significant in any of the three disease strata, it is included in this table along with
the permutation p-values for all three strata.
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Table 6.3: Significant three-way interactions for CSF tau.
Interaction N MCI AD
APOE4 x CD2AP x PICALM 0.086* 0.969 0.998
APOE4 x ABCA7 x NME8 0.080* 0.656 0.984
APOE4 x CR1 x MS4A6A 0.836 0.065* 0.987
APOE4 x MEF2C x CD2AP 0.988 0.998 0.043**
APOE4 x TREM2 x ZCWPW1 0.981 1.000 0.084*
APOE4 x MAPT x CELF1 0.845 0.983 0.093*
6.4 QMDR Results
Table 6.6 displays the candidate two-way and three-way interactions for CSF tau
selected by the QMDR analysis, and identifies which candidate interaction was se-
lected as the optimal interaction. Interactions printed in bold face indicate those that
were identified as significant (permutation p-value less than .10) in the AQMDR anal-
ysis. Note that for the quantitative outcome variable, CSF tau, all of the interactions
identified as optimal by QMDR were also selected by AQMDR (with c = .10) for
inclusion in the Arbitrary Cutoff Aggregated Score. For disease stratum N, APOE4
x INPP5D x PTK2B was selected as the candidate three-way interaction in QMDR,
but the permutation p-value obtained for that interaction in AQMDR was 0.327.
As we saw in table 6.3, two three-way interactions were identified as significant by
AQMDR, neither of which were APOE4 x INPP5D x PTK2B. For disease stratum
MCI, APOE4 x PSEN1 was selected as the candidate two-way interaction by QMDR,
but the AQMDR permutation p-value was 0.180. AQMDR did not identify any signif-
icant two-way interactions for disease stratum MCI. For disease stratum AD, APOE4
x SLC24A4 (which had an AQMDR permutation p-value of 1.000) was identified as
a candidate interaction in QMDR. AQMDR did not identify any significant two-way
interactions in the AD stratum.
Table 6.7 displays the candidate two-way and three-way interactions for CSF Aβ
selected by the QMDR analysis, and identifies which candidate interaction was se-
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Table 6.4: Two-way interaction permutation p-values for CSF Aβ.
SNP Gene N MCI AD
rs6656401 CR1 0.527 0.824 0.776
rs6733839 BIN1 0.799 0.848 0.933
rs35349669 INPP5D 0.838 0.971 0.983
rs190982 MEF2C 0.998 0.883 0.403
rs75932628 TREM2 1.000 1.000 1.000
rs10948363 CD2AP 1.000 0.945 0.625
rs2718058 NME8 0.705 0.986 0.871
rs1476679 ZCWPW1 0.595 0.632 0.611
rs11771145 EPHA1 0.867 0.956 0.660
rs28834970 PTK2B 1.000 0.011** 0.896
rs9331896 CLU 1.000 0.780 0.487
rs10838725 CELF1 0.988 0.839 1.000
rs983392 MS4A6A 0.945 0.616 1.000
rs10792832 PICALM 0.706 0.973 0.878
rs11218343 SORL1 1.000 1.000 1.000
rs17125944 FERMT2 0.999 0.842 0.710
rs17125721 PSEN1 0.707 0.180 1.000
rs10498633 SLC24A4 0.634 1.000 1.000
rs8070723 MAPT 0.617 0.986 0.988
rs8093731 DSG2 1.000 0.806 0.984
rs4147929 ABCA7 0.995 0.977 0.984
rs3865444 CD33 0.961 0.971 0.872
rs7274581 CASS4 0.712 1.000 0.632
lected as the optimal interaction. Interactions printed in bold face indicate those
that were identified as significant (permutation p-value less than .10) in the AQMDR
analysis. In disease stratum MCI, both candidate interactions were also identified
as significant by AQMDR. For disease stratum N, APOE4 x MAPT was selected
as the two-way candidate interaction by QMDR. However, this interaction yielded
a permutation p-value of 0.617 in the AQMDR analysis. AQMDR did not identify
any significant two-way interactions within the N disease stratum. QMDR identified
APOE4 x BIN1 x PICALM as the candidate three-way interaction (as well as the op-
timal interaction) for the N stratum, yet this interaction yielded an AQMDR p-value
of 0.238. AQMDR identified two significant three-way interactions for the N group,
neither of which were APOE4 x BIN1 x PICALM. Within the AD group, APOE4
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Table 6.5: Significant three-way interactions for CSF Aβ.
Interaction N MCI AD
APOE4 x CR1 x SLC24A4 0.067* 0.986 0.518
APOE4 x BIN1 x SLC24A4 0.098* 0.539 0.997
APOE4 x PTK2B x MAPT 0.986 0.100* 0.989
APOE4 x PTK2B x TREM2 0.999 0.021** 0.936
APOE4 x PTK2B x NME8 0.698 0.074* 0.956
APOE4 x PTK2B x ZCWPW1 0.941 0.012* 0.642
APOE4 x PTK2B x CELF1 1.000 0.099* 0.553
APOE4 x PTK2B x SORL1 1.000 0.011** 0.697
APOE4 x PTK2B x FERMT2 0.983 0.016** 0.950
APOE4 x PTK2B x PSEN1 0.985 0.031** 0.980
APOE4 x PTK2B x DSG2 0.827 0.014** 0.584
APOE4 x PTK2B x ABCA7 0.999 0.085* 0.270
APOE4 x PTK2B x CD33 0.993 0.008** 0.970
APOE4 x PTK2B x CASS4 0.930 0.077* 0.688
Table 6.6: QMDR candidate interactions for CSF tau.
Strat. Two-way Candidate Three-way Candidate Optimal
N APOE4 x ABCA7 APOE4 x INPP5D x PTK2B two-way
MCI APOE4 x PSEN1 APOE4 x CR1 x MS4A6A three-way
AD APOE4 x SLC24A4 APOE4 x MAPT x CELF1 three-way
x TREM2 and APOE4 x CD2AP x CLU were selected as candidate interactions
by QMDR, and yielded respective AQMDR permutation p-values of 1.000 and 0.329.
AQMDR did not identify any significant two-way or three-way interactions for the
AD disease stratum.
Table 6.7: QMDR candidate interactions for CSF Aβ.
Strat. Two-way Candidate Three-way Candidate Optimal
N APOE4 x MAPT APOE4 x BIN1 x PICALM three-way
MCI APOE4 x PTK2B APOE4 x PTK2B x CD33 two-way
AD APOE4 x TREM2 APOE4 x CD2AP x CLU two-way
6.5 Model Implementation
The results described in the previous sections for both CSF tau and CSF Aβ were
implemented in linear models, and these models were evaluated using training R2
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values. To illustrate the model implementation process (steps 4-6 from section 6.2
above) for AQMDR, we will consider the quantitative outcome variable, CSF tau, and
focus on the N disease group. Recall from tables 6.2 and 6.3 that APOE4 x ABCA7,
APOE4 x ABCA7 x NME8, and APOE4 x CD2AP x PICALM yielded permutation
p-values less than the arbitrary cutoff of c = .10. The two-way aggregated score will
contain only the APOE4 x ABCA7 interaction and the three-way aggregated score
will contain both APOE4 x ABCA7 x NME8 and APOE4 x CD2AP x PICALM.
All other interactions will be ignored. As the two-way aggregated score is based
off of only one interaction, the score for each subject in the data set will be the
“high”/“low” classification (1 for “high” or “0” for low) assigned to the subject in the
AQMDR classification. That is, the value of this aggregated score for each subject
will be 0, or 1. The three-way aggregated score is based on two interactions, and for
each subject will be the sum of the “high”/“low” classification value from APOE4 x
ABCA7 x NME8 and the “high”/“low” classification value from APOE4 x CD2AP x
PICALM. That is, the value of this aggregated score for each subject will be 0, 1, or
2.
Before implementing the AQMDR and QMDR models, we first regressed the out-
come variable, CSF tau on the three covariates and the main effects of all SNPs which
are included in the aggregated scores and the optimal QMDR interaction (APOE4,
ABCA7, NME8, CD2AP, and PICALM ). We include all SNPs included in the aggre-
gated score and the QMDR optimal interaction in the interest of using the same set
of residuals as the quantitative outcome for the AQMDR model implementation and
the QMDR model implementation. Only those subjects in the N stratum with obser-
vations for all of these covariates and relevant SNPs were included in the analysis.
For the AQMDR model implementation, the residuals from the previously men-
tioned regression model were used as the response in a linear regression model with
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the aggregated scores as predictors. Using the Simultaneous Inclusion method de-
scribed in chapter 3, the two-way aggregated score and the three-way aggregated
score were included in the linear model simultaneously. For the QMDR implementa-
tion, the same set of residuals used for the AQMDR implementation were used as the
response in a linear regression model with the “high”/“low” classification of subjects
based on the optimal interaction (APOE4 x ABCA7 in our example) as the only
predictor.
This process was repeated for each disease stratum, and again for CSF Aβ in
the three disease strata. Training R2’s for each of the QMDR and AQMDR linear
models were recorded in tables 6.8 and 6.9. For CSF tau (table 6.8), the AQMDR
implementation yields higher training R2’s for disease strata N and AD. Note that
the two implementations were identical for stratum MCI because AQMDR identified
only one significant interaction, which was the same interaction identified as optimal
by QMDR.
Table 6.8: Training R2’s for CSF tau.
Stratum AQMDR R2 QMDR R2
N 0.2342 0.0730
MCI 0.1435 0.1435
AD 0.2790 0.1884
For CSF Aβ, in disease stratum N, AQMDR yielded a slightly higher training R2
than QMDR. Recall that in this stratum, neither candidate interaction from QMDR
was identified as significant by AQMDR. As AQMDR still yielded a training R2 value
comparable to that of QMDR, perhaps AQMDR identified two important three-way
interactions, yet failed to pick up on APOE4 x BIN1 x PICALM (which was selected
as optimal by QMDR). This may have been addressed with a larger ACAS cutoff
value, c. For disease stratum MCI, the AQMDR implementation yielded a higher
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training R2 than QMDR. Recall that in this case, AQMDR identified both of the
QMDR candidate interactions as significant, and many others as well. This may
be the type of situation for which AQMDR was designed. That is, there may be
many gene-to-gene interactions present in nature. If this is the case, QMDR ignores
all but one of these interactions due to the selection of a single optimal interaction.
AQMDR would be advantageous in this case, as it incorporates the effects of multiple
gene-to-gene interactions based on permutation p-values. For the AD stratum, recall
that AQMDR did not identify any significant two-way or three-way interactions, thus
there was no aggregated score to implement in a model. QMDR selected an optimal
interaction by default, but when this interaction was implemented in a linear model,
the model yielded a very low training R2 value of 4.685 x 10−32, likely due to the
regression of the main effects.
Table 6.9: Training R2’s for CSF Aβ.
Stratum AQMDR R2 QMDR R2
N 0.2717 0.2369
MCI 0.4373 0.1512
AD - 4.685 x 10−32
6.6 Confounding
One concern surrounding the AQMDR results is the possibility of confounding.
For example, for CSF tau within disease stratum N, the two-way interaction between
APOE4 and ABCA7 was identified as significant. The three-way interaction among
APOE4, ABCA7 and NME8 was also identified as significant. It is possible that this
three-way interaction was only significant due to confounding caused by APOE4 x
ABCA7. If this is the case, inclusion of both of these interactions in the AQMDR
implementation would be redundant. In order to explore this possibility, we have
displayed the “high”/“low” classifications assigned to the significant interactions by
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AQMDR in figure 6.1. In this figure, the shaded multifactor cells are those classified
as “high” (1), and the white cells are those classified as “low”.
Based on the classification assigned to the two-way interaction, we would expect a
three-way interaction induced by confounding to exhibit the same pattern of classifi-
cation. That is, we expect the three-way interaction to exhibit“high”classifications in
multifactor cells where (APOE4 = 0 ∩ ABCA7 = 1 ), (APOE4 = 1 ∩ ABCA7 = 0 ),
(APOE4 = 1 ∩ ABCA7 = 2 ), or (APOE4 = 2 ∩ ABCA7 = 1 ). However, when we
observe the classification pattern of the three-way interaction among APOE4, ABCA7
and NME8, we see that the “high” multifactor cells extend beyond the APOE4 and
ABCA7 combinations identified in the two-way interaction. Based on these patterns,
we cannot conclude that the significance of the three-way interaction is merely a
consequence of the two-way interaction.
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Figure 6.1: “High”/“low” classifications for significant AQMDR interactions for CSF
tau in stratum N.
For CSF Aβ within the MCI stratum, the interaction between APOE4 and PTK2B
was identified as significant in AQMDR. Twelve three-way interactions were also iden-
tified, all of which contain APOE4 and PTK2B. Figure 6.2 illustrates the“high”/“low”
classifications assigned to the significant interactions by AQMDR. In this figure, the
shaded multifactor cells are those classified as “high”, and the white cells are those
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classified as “low”. As we saw with the CSF tau interactions, the classification pat-
terns extend beyond those we would expect based on confounding caused by the
two-way interaction, and the three-way interactions all display distinct “high”/“low”
classification patterns. Thus, we cannot conclude that the three-way interactions are
significant due only to the significance of the two-way interaction.
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Figure 6.2: “High”/“low” classifications for significant AQMDR interactions for CSF
Aβ in stratum MCI.
115
6.7 Future Work
In this chapter, we have provided some interesting results regarding the analysis
of ADNI data using AQMDR and QMDR. We have provided data-driven evidence
that AQMDR may provide better predictions and identification of significant inter-
actions than QMDR in situations where more than one interaction is influencing a
quantitative trait. Future analysis of the sample data will be preceded by imputation
of the data to eliminate missing observations. Data with fewer missing SNP values
will allow for consistent sample sizes across all interaction considerations, and will
also facilitate the implementation of the more complex aggregated scores (CWAS and
HAS) discussed in chapter 2 of this work. A larger sample size for each interaction
consideration will also provide higher power. It is also important to note that if a
bonferroni correction were used to correct for multiple tests, none of the interactions
identified as significant with a cutoff of c = .10 in AQMDR would have been identified
as significant using the correction. In the continuation of this study with imputed
data, we hope to explore the necessity for correction of multiple tests.
In addition to the continuation of this data application, there are also avenues to
explore regarding the AQMDR method. Future work may include the consideration
of outcome variables in vector form. For example, rather than performing separate
analyses regarding CSF tau and Aβ, we may be able to use the AQMDR framework
to consider the vectorized outcome (tau, Aβ). It may also be of interest to consider
alternate approaches to the categorization of multifactor cells. For example, we may
want to consider weighting each multifactor class within an interaction with some
continuous score between 0 and 1. In addition, AQMDR is based on an extension
of QMDR, but could easily be adapted to incorporate Generalized MDR (GMDR)
[10]. As the GMDR approach yields a “high”/“low” classification of multifactor cells
within each interaction as well as a p-value associated with each k-way interaction,
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the method easily lends itself to the aggregated scores discussed in this work.
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